The	O
granulocyte-macrophage	B-DNA
colony-stimulating	I-DNA
factor	I-DNA
promoter	I-DNA
cis-acting	I-DNA
element	I-DNA
CLE0	B-DNA
mediates	O
induction	O
signals	O
in	O
T	B-cell_type
cells	I-cell_type
and	O
is	O
recognized	O
by	O
factors	O
related	O
to	O
AP1	B-protein
and	O
NFAT	B-protein
.	O

Expression	O
of	O
the	O
granulocyte-macrophage	B-DNA
colony-stimulating	I-DNA
factor	I-DNA
(	I-DNA
GM-CSF	I-DNA
)	I-DNA
gene	I-DNA
in	O
T	O
cells	O
is	O
activated	O
by	O
the	O
combination	O
of	O
phorbol	O
ester	O
(	O
phorbol	O
myristate	O
acetate	O
)	O
and	O
calcium	O
ionophore	O
(	O
A23187	O
)	O
,	O
which	O
mimic	O
antigen	O
stimulation	O
through	O
the	O
T-cell	B-protein
receptor	I-protein
.	O

We	O
have	O
previously	O
shown	O
that	O
a	O
fragment	O
containing	O
bp	B-DNA
-95	I-DNA
to	I-DNA
+27	I-DNA
of	O
the	O
mouse	B-DNA
GM-CSF	I-DNA
promoter	I-DNA
can	O
confer	O
inducibility	O
to	O
reporter	B-DNA
genes	I-DNA
in	O
the	O
human	B-cell_line
Jurkat	I-cell_line
T-cell	I-cell_line
line	I-cell_line
.	O

Here	O
we	O
use	O
an	O
in	O
vitro	O
transcription	O
system	O
to	O
demonstrate	O
that	O
a	O
cis-acting	B-DNA
element	I-DNA
(	O
positions	B-DNA
-54	I-DNA
to	I-DNA
-40	I-DNA
)	O
,	O
referred	O
to	O
as	O
CLE0	B-DNA
,	O
is	O
a	O
target	O
for	O
the	O
induction	O
signals	O
.	O

We	O
observed	O
induction	O
with	O
templates	O
containing	O
intact	O
CLE0	B-DNA
but	O
not	O
with	O
templates	O
with	O
deleted	B-DNA
or	I-DNA
mutated	I-DNA
CLE0	I-DNA
.	O

We	O
also	O
observed	O
that	O
two	O
distinct	O
signals	O
were	O
required	O
for	O
the	O
stimulation	O
through	O
CLE0	B-DNA
,	O
since	O
only	O
extracts	O
from	O
cells	O
treated	O
with	O
both	O
phorbol	O
myristate	O
acetate	O
and	O
A23187	O
supported	O
optimal	O
induction	O
.	O

Stimulation	O
probably	O
was	O
mediated	O
by	O
CLE0-binding	B-protein
proteins	I-protein
because	O
depletion	O
of	O
these	O
proteins	O
specifically	O
reduced	O
GM-CSF	B-protein
transcription	O
.	O

One	O
of	O
the	O
binding	B-protein
factors	I-protein
possessed	O
biochemical	O
and	O
immunological	O
features	O
identical	O
to	O
those	O
of	O
the	O
transcription	B-protein
factor	I-protein
AP1	I-protein
.	O

Another	O
factor	O
resembled	O
the	O
T-cell-specific	B-protein
factor	I-protein
NFAT	I-protein
.	O

The	O
characteristics	O
of	O
these	O
two	O
factors	O
are	O
consistent	O
with	O
their	O
involvement	O
in	O
GM-CSF	O
induction	O
.	O

The	O
presence	O
of	O
CLE0-like	B-DNA
elements	I-DNA
in	O
the	O
promoters	B-DNA
of	O
interleukin-3	B-DNA
(	I-DNA
IL-3	I-DNA
)	I-DNA
,	I-DNA
IL-4	I-DNA
,	I-DNA
IL-5	I-DNA
,	I-DNA
GM-CSF	I-DNA
,	I-DNA
and	I-DNA
NFAT	I-DNA
sites	I-DNA
in	O
the	O
IL-2	B-DNA
promoter	I-DNA
suggests	O
that	O
the	O
factors	O
we	O
detected	O
,	O
or	O
related	O
factors	O
that	O
recognize	O
these	O
sites	O
,	O
may	O
account	O
for	O
the	O
coordinate	O
induction	O
of	O
these	O
genes	O
during	O
T-cell	B-cell_type
activation	O
.	O

MoLECcULAR	NULL
aND	NULL
CELLULAR	NULL
BroLoGYy	NULL
,	NULL
Dec.	NULL
1993	NULL
,	NULL
p.	NULL
7399-7407	NULL
0270-7306/93/127399-09	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1993	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

13	NULL
,	NULL
No	NULL
.	NULL

12	NULL
The	NULL
Granulocyte-Macrophage	NULL
Colony-Stimulating	NULL
Factor	NULL
Promoter	NULL
cis-Acting	NULL
Element	NULL
CLEO	NULL
Mediates	NULL
Induction	NULL
Signals	NULL
in	NULL
T	NULL
Cells	NULL
and	NULL
Is	NULL
Recognized	NULL
by	NULL
Factors	NULL
Related	NULL
to	NULL
API	NULL
and	NULL
NFAT	NULL
ESTEBAN	NULL
S.	NULL
MASUDA	NULL
,	NULL
HIROSHI	NULL
TOKUMITSU	NULL
,	NULL
``	NULL
AKIO	NULL
TSUBOI	NULL
,	NULL
'	NULL
JOSEPH	NULL
SHLOMALI	NULL
,	NULL
*	NULL
PEGGY	NULL
HUNG	NULL
,	NULL
``	NULL
KEN-ICHI	NULL
ARAI	NULL
,	NULL
``	NULL
anp	NULL
NAOKO	NULL
ARATL*	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
DNAX	NULL
Research	NULL
Institute	NULL
of	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
,	NULL
901	NULL
California	NULL
Avenue	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
California	NULL
94304-1104	NULL
``	NULL
;	NULL
Department	NULL
of	NULL
Cellular	NULL
Biochemistry	NULL
,	NULL
The	NULL
Hebrew	NULL
University	NULL
of	NULL
Jerusalem	NULL
,	NULL
Hadassah	NULL
Medical	NULL
School	NULL
,	NULL
Jerusalem	NULL
91010	NULL
,	NULL
IsraeP	NULL
;	NULL
and	NULL
Department	NULL
of	NULL
Molecular	NULL
and	NULL
Developmental	NULL
Biology	NULL
,	NULL
The	NULL
Institute	NULL
of	NULL
Medical	NULL
Science	NULL
,	NULL
University	NULL
of	NULL
Tokyo	NULL
,	NULL
Tokyo	NULL
108	NULL
,	NULL
Japan	NULL
Received	NULL
14	NULL
May	NULL
1993/Returned	NULL
for	NULL
modification	NULL
24	NULL
July	NULL
1993/Accepted	NULL
8	NULL
September	NULL
1993	NULL
Expression	NULL
of	NULL
the	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
gene	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
activated	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
phorbol	NULL
ester	NULL
(	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
)	NULL
and	NULL
calcium	NULL
ionophore	NULL
(	NULL
A23187	NULL
)	NULL
,	NULL
which	NULL
mimic	NULL
antigen	NULL
stimulation	NULL
through	NULL
the	NULL
T-cell	NULL
receptor	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
a	NULL
fragment	NULL
containing	NULL
bp	NULL
-95	NULL
to	NULL
+27	NULL
of	NULL
the	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
can	NULL
confer	NULL
inducibility	NULL
to	NULL
reporter	NULL
genes	NULL
in	NULL
the	NULL
human	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
.	NULL

Here	NULL
we	NULL
use	NULL
an	NULL
in	NULL
vitro	NULL
transcription	NULL
system	NULL
to	NULL
demonstrate	NULL
that	NULL
a	NULL
cis-acting	NULL
element	NULL
(	NULL
positions	NULL
-54	NULL
to	NULL
-40	NULL
)	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
CLEO	NULL
,	NULL
is	NULL
a	NULL
target	NULL
for	NULL
the	NULL
induction	NULL
signals	NULL
.	NULL

We	NULL
observed	NULL
induction	NULL
with	NULL
templates	NULL
containing	NULL
intact	NULL
CLEO	NULL
but	NULL
not	NULL
with	NULL
templates	NULL
with	NULL
deleted	NULL
or	NULL
mutated	NULL
CLEO	NULL
.	NULL

We	NULL
also	NULL
observed	NULL
that	NULL
two	NULL
distinct	NULL
signals	NULL
were	NULL
required	NULL
for	NULL
the	NULL
stimulation	NULL
through	NULL
CLEO	NULL
,	NULL
since	NULL
only	NULL
extracts	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
both	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
and	NULL
A23187	NULL
supported	NULL
optimal	NULL
induction	NULL
.	NULL

Stimulation	NULL
probably	NULL
was	NULL
mediated	NULL
by	NULL
CLEO-binding	NULL
proteins	NULL
because	NULL
depletion	NULL
of	NULL
these	NULL
proteins	NULL
specifically	NULL
reduced	NULL
GM-CSF	NULL
transcription	NULL
.	NULL

One	NULL
of	NULL
the	NULL
binding	NULL
factors	NULL
possessed	NULL
biochemical	NULL
and	NULL
immunological	NULL
features	NULL
identical	NULL
to	NULL
those	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
AP1	NULL
.	NULL

Another	NULL
factor	NULL
resembled	NULL
the	NULL
T-cell-specific	NULL
factor	NULL
NFAT	NULL
.	NULL

The	NULL
characteristics	NULL
of	NULL
these	NULL
two	NULL
factors	NULL
are	NULL
consistent	NULL
with	NULL
their	NULL
involvement	NULL
in	NULL
GM-CSF	NULL
induction	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
CLEO-like	NULL
elements	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
interleukin-3	NULL
(	NULL
IL-3	NULL
)	NULL
,	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
NFAT	NULL
sites	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
suggests	NULL
that	NULL
the	NULL
factors	NULL
we	NULL
detected	NULL
,	NULL
or	NULL
related	NULL
factors	NULL
that	NULL
recognize	NULL
these	NULL
sites	NULL
,	NULL
may	NULL
account	NULL
for	NULL
the	NULL
coordinate	NULL
induction	NULL
of	NULL
these	NULL
genes	NULL
during	NULL
T-cell	NULL
activation	NULL
.	NULL

When	NULL
T	NULL
lymphocytes	NULL
encounter	NULL
antigen	NULL
in	NULL
the	NULL
proper	NULL
context	NULL
,	NULL
they	NULL
are	NULL
activated	NULL
and	NULL
produce	NULL
an	NULL
array	NULL
of	NULL
protein	NULL
mediators	NULL
that	NULL
regulate	NULL
a	NULL
variety	NULL
of	NULL
immune	NULL
responses	NULL
and	NULL
inflammation	NULL
(	NULL
3	NULL
,	NULL
9	NULL
)	NULL
.	NULL

These	NULL
mediators	NULL
are	NULL
collectively	NULL
called	NULL
T-cell-derived	NULL
cytokines	NULL
and	NULL
include	NULL
a	NULL
variety	NULL
of	NULL
interleu-kins	NULL
,	NULL
hemopoietic	NULL
growth	NULL
factors	NULL
,	NULL
and	NULL
inflammation	NULL
factors	NULL
.	NULL

The	NULL
mechanisms	NULL
that	NULL
lead	NULL
to	NULL
coordinate	NULL
production	NULL
of	NULL
these	NULL
cytokines	NULL
are	NULL
being	NULL
actively	NULL
investigated	NULL
.	NULL

For	NULL
most	NULL
cytokines	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
their	NULL
expression	NULL
is	NULL
regulated	NULL
predominantly	NULL
by	NULL
initiation	NULL
of	NULL
transcription	NULL
of	NULL
their	NULL
genes	NULL
(	NULL
3	NULL
,	NULL
5	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Comparisons	NULL
of	NULL
the	NULL
regions	NULL
upstream	NULL
of	NULL
cytokine	NULL
gene	NULL
promoters	NULL
have	NULL
revealed	NULL
a	NULL
number	NULL
of	NULL
conserved	NULL
lymphokine	NULL
elements	NULL
:	NULL
CLE1	NULL
(	NULL
CK1	NULL
)	NULL
,	NULL
CLE2	NULL
(	NULL
CK2	NULL
)	NULL
,	NULL
and	NULL
CLEO	NULL
(	NULL
3	NULL
,	NULL
20	NULL
,	NULL
32	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
immunosuppressants	NULL
such	NULL
as	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
reduce	NULL
or	NULL
totally	NULL
inhibit	NULL
expression	NULL
of	NULL
cytokines	NULL
in	NULL
T	NULL
cells	NULL
suggests	NULL
that	NULL
there	NULL
exists	NULL
a	NULL
common	NULL
link	NULL
in	NULL
their	NULL
regulation	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
coupling	NULL
of	NULL
activation	NULL
signals	NULL
received	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
to	NULL
the	NULL
initiation	NULL
of	NULL
transcription	NULL
seems	NULL
to	NULL
involve	NULL
many	NULL
components	NULL
,	NULL
each	NULL
of	NULL
which	NULL
may	NULL
be	NULL
regulated	NULL
during	NULL
the	NULL
process	NULL
of	NULL
cell	NULL
activation	NULL
.	NULL

Antigen	NULL
recognition	NULL
in	NULL
the	NULL
context	NULL
of	NULL
an	NULL
antigen-presenting	NULL
cell	NULL
by	NULL
the	NULL
T-cell	NULL
receptor	NULL
rapidly	NULL
switches	NULL
on	NULL
several	NULL
signaling	NULL
events	NULL
,	NULL
including	NULL
protein	NULL
phosphorylation	NULL
,	NULL
calcium	NULL
mobilization	NULL
,	NULL
and	NULL
inositol	NULL
phospholipid	NULL
hydrolysis	NULL
(	NULL
15	NULL
,	NULL
40	NULL
)	NULL
.	NULL

With	NULL
regards	NULL
to	NULL
transcriptional	NULL
activation	NULL
,	NULL
these	NULL
signals	NULL
can	NULL
be	NULL
bypassed	NULL
by	NULL
the	NULL
use	NULL
of	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

7399	NULL
phorbol	NULL
esters	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
[	NULL
PMA	NULL
]	NULL
)	NULL
and	NULL
calcium	NULL
ionophores	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
A23187	NULL
)	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
both	NULL
of	NULL
these	NULL
agents	NULL
causes	NULL
maximal	NULL
induction	NULL
of	NULL
most	NULL
cytokine	NULL
genes	NULL
(	NULL
4	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Yet	NULL
the	NULL
absolute	NULL
requirement	NULL
for	NULL
the	NULL
action	NULL
of	NULL
both	NULL
PMA	NULL
and	NULL
A23187	NULL
varies	NULL
for	NULL
different	NULL
cytokines	NULL
,	NULL
indicating	NULL
that	NULL
one	NULL
pathway	NULL
sometimes	NULL
dominates	NULL
over	NULL
the	NULL
other	NULL
(	NULL
4	NULL
)	NULL
.	NULL

We	NULL
have	NULL
focused	NULL
on	NULL
the	NULL
regulation	NULL
of	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Both	NULL
PMA	NULL
and	NULL
A23187	NULL
are	NULL
required	NULL
to	NULL
induce	NULL
expression	NULL
of	NULL
GM-CSF	NULL
;	NULL
CsA	NULL
or	NULL
FK506	NULL
can	NULL
completely	NULL
inhibit	NULL
this	NULL
induction	NULL
(	NULL
4	NULL
)	NULL
.	NULL

After	NULL
T-cell	NULL
stimulation	NULL
,	NULL
GM-CSF	NULL
mRNA	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
2	NULL
to	NULL
4	NULL
h.	NULL
The	NULL
presence	NULL
of	NULL
this	NULL
mRNA	NULL
is	NULL
largely	NULL
due	NULL
to	NULL
transcription	NULL
initiation	NULL
(	NULL
5	NULL
,	NULL
19	NULL
,	NULL
25	NULL
)	NULL
and	NULL
requires	NULL
the	NULL
synthesis	NULL
of	NULL
specific	NULL
factors	NULL
,	NULL
since	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
,	NULL
a	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
,	NULL
blocks	NULL
GM-CSF	NULL
expression	NULL
at	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
stimulation	NULL
(	NULL
27	NULL
,	NULL
29	NULL
)	NULL
.	NULL

We	NULL
have	NULL
been	NULL
characterizing	NULL
presumed	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
5°	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
mouse	NULL
GM-CSF	NULL
gene	NULL
.	NULL

This	NULL
5	NULL
'	NULL
region	NULL
is	NULL
highly	NULL
conserved	NULL
between	NULL
murine	NULL
and	NULL
human	NULL
clones	NULL
;	NULL
e.g	NULL
.	NULL

,	NULL
there	NULL
is	NULL
approximately	NULL
85	NULL
%	NULL
identity	NULL
over	NULL
the	NULL
region	NULL
extending	NULL
about	NULL
360	NULL
bp	NULL
upstream	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Using	NULL
transient	NULL
transfection	NULL
assays	NULL
of	NULL
5	NULL
deletion	NULL
constructs	NULL
in	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
Jurkat	NULL
cell	NULL
line	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
region	NULL
from	NULL
positions	NULL
-95	NULL
to	NULL
+27	NULL
of	NULL
the	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
region	NULL
was	NULL
capable	NULL
of	NULL
mediating	NULL
induction	NULL
in	NULL
response	NULL
to	NULL
PMA	NULL
plus	NULL
A23187	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Further	NULL
analysis	NULL
identified	NULL
two	NULL
essential	NULL
elements	NULL
within	NULL
this	NULL
sequence	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
GM-	NULL
«	NULL
B/GC	NULL
and	NULL
CLEO	NULL
elements	NULL
.	NULL

7400	NULL
MASUDA	NULL
ET	NULL
AL	NULL
.	NULL

GM-	NULL
«	NULL
B/GC	NULL
is	NULL
a	NULL
23-bp	NULL
cis-acting	NULL
region	NULL
(	NULL
positions	NULL
-95	NULL
to	NULL
-73	NULL
)	NULL
that	NULL
consists	NULL
of	NULL
two	NULL
binding	NULL
sites	NULL
:	NULL
GM-	NULL
«	NULL
B	NULL
(	NULL
previously	NULL
called	NULL
GM2	NULL
)	NULL
and	NULL
a	NULL
GC	NULL
box	NULL
.	NULL

GM-	NULL
«	NULL
B	NULL
defines	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
a	NULL
protein	NULL
induced	NULL
by	NULL
PMA	NULL
whose	NULL
characteristics	NULL
are	NULL
identical	NULL
to	NULL
those	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
30	NULL
,	NULL
39	NULL
)	NULL
.	NULL

The	NULL
GC	NULL
box	NULL
defines	NULL
a	NULL
site	NULL
for	NULL
constitutively	NULL
bound	NULL
proteins	NULL
(	NULL
36	NULL
)	NULL
.	NULL

The	NULL
other	NULL
element	NULL
,	NULL
CLEO	NULL
(	NULL
positions	NULL
-54	NULL
to	NULL
-40	NULL
)	NULL
,	NULL
lies	NULL
near	NULL
the	NULL
TATA	NULL
box	NULL
;	NULL
its	NULL
sequence	NULL
is	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
elements	NULL
present	NULL
in	NULL
the	NULL
regulatory	NULL
regions	NULL
for	NULL
the	NULL
interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
and	NULL
IL-5	NULL
genes	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
report	NULL
that	NULL
CLEO	NULL
is	NULL
essential	NULL
for	NULL
induction	NULL
of	NULL
transcription	NULL
at	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

These	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
vitro	NULL
with	NULL
a	NULL
transcription	NULL
system	NULL
prepared	NULL
from	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
found	NULL
that	NULL
CLEO	NULL
is	NULL
recognized	NULL
by	NULL
two	NULL
factors	NULL
,	NULL
one	NULL
with	NULL
the	NULL
characteristics	NULL
of	NULL
transcription	NULL
factor	NULL
AP1	NULL
,	NULL
and	NULL
the	NULL
other	NULL
with	NULL
features	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
NFAT	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
implication	NULL
of	NULL
AP1	NULL
,	NULL
NFAT	NULL
,	NULL
or	NULL
related	NULL
factors	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
other	NULL
T-cell-derived	NULL
cytokines	NULL
through	NULL
CLEO-like	NULL
elements	NULL
is	NULL
discussed	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Oligonucleotides	NULL
and	NULL
immunoreagents	NULL
.	NULL

The	NULL
oligonucleotides	NULL
used	NULL
for	NULL
competition	NULL
and	NULL
mobility	NULL
shift	NULL
assays	NULL
contained	NULL
the	NULL
following	NULL
sequences	NULL
(	NULL
only	NULL
one	NULL
strand	NULL
is	NULL
shown	NULL
;	NULL
sequence	NULL
overhangs	NULL
are	NULL
presented	NULL
in	NULL
lowercase	NULL
)	NULL
:	NULL
CLEO	NULL
element	NULL
(	NULL
20	NULL
)	NULL
,	NULL
5'-gatcGTCACCATTAATCATTITTCCTCTAA	NULL
CTGT-3	NULL
'	NULL
;	NULL
API	NULL
site	NULL
(	NULL
22	NULL
)	NULL
,	NULL
gm-mul,2	NULL
(	NULL
36	NULL
)	NULL
,	NULL
5'-gatcAGGTAGTTCCCCCGCCCCCC-3	NULL
'	NULL
;	NULL
IgkB	NULL
(	NULL
21	NULL
)	NULL
,	NULL
5-gatcTCAACAGAGGGGACTTITTCCGAGAG	NULL
GCC-3	NULL
'	NULL
;	NULL
and	NULL
NFAT	NULL
site	NULL
(	NULL
11	NULL
)	NULL
,	NULL
5'-gatcGGAGGAAAAACT	NULL
GTTTCATACAGAAGGCGT-3	NULL
'	NULL
.	NULL

GM47	NULL
and	NULL
GM43,47	NULL
correspond	NULL
to	NULL
the	NULL
CLEO	NULL
oligonucleotide	NULL
with	NULL
a	NULL
single	NULL
substitution	NULL
at	NULL
position	NULL
-47	NULL
and	NULL
substitutions	NULL
at	NULL
both	NULL
positions	NULL
-43	NULL
and	NULL
-47	NULL
,	NULL
respectively	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Rabbit	NULL
polyclonal	NULL
antisera	NULL
raised	NULL
against	NULL
the	NULL
N-terminal	NULL
half	NULL
(	NULL
«	NULL
Fos-alu	NULL
)	NULL
or	NULL
the	NULL
basic	NULL
region	NULL
(	NULL
«	NULL
Fos-WB2.3	NULL
)	NULL
of	NULL
c-Fos	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
T.	NULL
Kerppola	NULL
and	NULL
T.	NULL
Curran	NULL
(	NULL
Roche	NULL
Institute	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Nutley	NULL
,	NULL
N.J.	NULL
)	NULL
.	NULL

Other	NULL
immunoglobulin	NULL
G	NULL
antibodies	NULL
used	NULL
were	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

Plasmids	NULL
.	NULL

All	NULL
plasmids	NULL
used	NULL
as	NULL
templates	NULL
for	NULL
in	NULL
vitro	NULL
transcription	NULL
were	NULL
digested	NULL
with	NULL
Fnu4HI	NULL
,	NULL
except	NULL
for	NULL
the	NULL
adenovirus	NULL
major	NULL
late	NULL
(	NULL
AdML	NULL
)	NULL
promoter	NULL
template	NULL
,	NULL
which	NULL
was	NULL
prepared	NULL
by	NULL
NdeI	NULL
digestion	NULL
of	NULL
plasmid	NULL
pDNAdML	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Plasmids	NULL
pGM6OLuc	NULL
,	NULL
pGM32Luc	NULL
,	NULL
pGM19Luc	NULL
,	NULL
and	NULL
pGM+3Luc	NULL
were	NULL
constructed	NULL
by	NULL
replacing	NULL
the	NULL
chloram-phenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
from	NULL
the	NULL
corresponding	NULL
CAT	NULL
constructs	NULL
(	NULL
19	NULL
)	NULL
with	NULL
the	NULL
luciferase	NULL
gene	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
constructions	NULL
of	NULL
pGM97Luc	NULL
(	NULL
also	NULL
referred	NULL
to	NULL
as	NULL
pKC1	NULL
)	NULL
,	NULL
pKC30	NULL
,	NULL
and	NULL
pIL2Luc-1	NULL
will	NULL
be	NULL
reported	NULL
elsewhere	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Plasmid	NULL
pKC30	NULL
is	NULL
analogous	NULL
to	NULL
p43-48	NULL
(	NULL
20	NULL
)	NULL
but	NULL
with	NULL
the	NULL
luciferase	NULL
reporter	NULL
instead	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

Plasmid	NULL
pIL2Luc1	NULL
,	NULL
which	NULL
contains	NULL
positions	NULL
-567	NULL
to	NULL
+47	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
,	NULL
was	NULL
derived	NULL
from	NULL
pIL2CAT-1	NULL
(	NULL
obtained	NULL
from	NULL
G.	NULL
Crabtree	NULL
,	NULL
Stanford	NULL
University	NULL
)	NULL
.	NULL

Plasmid	NULL
pGM6OLucl,2	NULL
(	NULL
36	NULL
)	NULL
is	NULL
analogous	NULL
to	NULL
pGM97Luc	NULL
but	NULL
has	NULL
a	NULL
reduced	NULL
linker	NULL
space	NULL
between	NULL
the	NULL
GM-	NULL
«	NULL
B/GC	NULL
and	NULL
CLEO	NULL
elements	NULL
(	NULL
39	NULL
)	NULL
,	NULL
giving	NULL
slightly	NULL
higher	NULL
transcriptional	NULL
activity	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
as	NULL
described	NULL
by	NULL
Miyatake	NULL
et	NULL
al	NULL
.	NULL

(	NULL
20	NULL
)	NULL
.	NULL

Unless	NULL
otherwise	NULL
men-tioned	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
PMA	NULL
at	NULL
50	NULL
ng/ml	NULL
and	NULL
A23187	NULL
at	NULL
1.0	NULL
M.	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
10	NULL
)	NULL
,	NULL
using	NULL
0.2	NULL
%	NULL
Nonidet	NULL
P-40	NULL
to	NULL
disrupt	NULL
the	NULL
cells	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Runoff	NULL
transcription	NULL
assays	NULL
were	NULL
carried	NULL
as	NULL
described	NULL
by	NULL
Miyatake	NULL
et	NULL
al	NULL
.	NULL

(	NULL
20	NULL
)	NULL
,	NULL
using	NULL
40	NULL
to	NULL
50	NULL
ug	NULL
of	NULL
protein	NULL
of	NULL
nuclear	NULL
extract	NULL
,	NULL
100	NULL
ng	NULL
of	NULL
Mor	NULL
.	NULL

Cer	NULL
.	NULL

BroL	NULL
.	NULL

template	NULL
DNA	NULL
,	NULL
and	NULL
a	NULL
final	NULL
KCl	NULL
concentration	NULL
of	NULL
100	NULL
mM	NULL
.	NULL

Radioactivity	NULL
in	NULL
runoff	NULL
transcripts	NULL
was	NULL
quantitated	NULL
by	NULL
using	NULL
the	NULL
PhosphorImager	NULL
system	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Depletion	NULL
of	NULL
CLEO-binding	NULL
proteins	NULL
was	NULL
performed	NULL
by	NULL
using	NULL
Dynabeads	NULL
M-280	NULL
streptavidin	NULL
(	NULL
Dynal	NULL
A/S	NULL
)	NULL
coupled	NULL
to	NULL
bio-tinylated	NULL
multimers	NULL
of	NULL
the	NULL
CLEO	NULL
element	NULL
as	NULL
described	NULL
by	NULL
Gabrielsen	NULL
et	NULL
al	NULL
.	NULL

(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
depletion	NULL
was	NULL
done	NULL
on	NULL
nuclear	NULL
extracts	NULL
from	NULL
PMA-A23187-stimulated	NULL
cells	NULL
that	NULL
were	NULL
adjusted	NULL
to	NULL
100	NULL
mM	NULL
KCl	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
mg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
per	NULL
ml	NULL
.	NULL

Mobility	NULL
shift	NULL
assays	NULL
.	NULL

Nuclear	NULL
extracts	NULL
used	NULL
for	NULL
runoff	NULL
transcription	NULL
assays	NULL
were	NULL
used	NULL
for	NULL
gel	NULL
shift	NULL
assays	NULL
.	NULL

Alternatively	NULL
,	NULL
nuclear	NULL
miniextracts	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
31	NULL
)	NULL
,	NULL
modified	NULL
as	NULL
follows	NULL
.	NULL

After	NULL
the	NULL
appropriate	NULL
treatments	NULL
,	NULL
2	NULL
x	NULL
10	NULL
``	NULL
to	NULL
5	NULL
x	NULL
10	NULL
``	NULL
Jurkat	NULL
cells	NULL
(	NULL
at	NULL
2	NULL
x	NULL
10°	NULL
cells/ml	NULL
!	NULL
)	NULL

were	NULL
collected	NULL
and	NULL
washed	NULL
once	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
then	NULL
with	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
N-2-hydroxyethylpiperazine-NV	NULL
'	NULL
-2-ethanesulfonic	NULL
acid	NULL
[	NULL
HEPES	NULL
;	NULL
pH	NULL
7.6	NULL
]	NULL
,	NULL
15	NULL
mM	NULL
KCl	NULL
,	NULL
2	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
10	NULL
mg	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
pellet	NULL
was	NULL
then	NULL
resuspended	NULL
on	NULL
ice	NULL
with	NULL
buffer	NULL
A	NULL
containing	NULL
0.2	NULL
%	NULL
Nonidet	NULL
P-40	NULL
and	NULL
passed	NULL
once	NULL
through	NULL
a	NULL
syringe	NULL
with	NULL
a	NULL
27.5-gauge	NULL
needle	NULL
.	NULL

Nuclei	NULL
were	NULL
gently	NULL
centrifuged	NULL
(	NULL
~800	NULL
x	NULL
g	NULL
)	NULL
,	NULL
resuspended	NULL
in	NULL
buffer	NULL
A	NULL
containing	NULL
0.25	NULL
M	NULL
sucrose	NULL
,	NULL
and	NULL
again	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
.	NULL

Nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
with	NULL
constant	NULL
shaking	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
with	NULL
40	NULL
to	NULL
100	NULL
ml	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
50	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
400	NULL
mM	NULL
KCl	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
10	NULL
mg	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
.	NULL

The	NULL
extract	NULL
was	NULL
centrifuged	NULL
,	NULL
and	NULL
the	NULL
supernatant	NULL
was	NULL
aliquoted	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

The	NULL
DNA-binding	NULL
reactions	NULL
were	NULL
performed	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
in	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
-10	NULL
%	NULL
glycerol-1	NULL
mM	NULL
EDTA-1	NULL
mM	NULL
DTT-50	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
per	NULL
ml-250	NULL
pg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
per	NULL
mIl-KCl	NULL
adjusted	NULL
to	NULL
100	NULL
mM-~0.5	NULL
ng	NULL
of	NULL
labeled	NULL
probe	NULL
(	NULL
~50,000	NULL
cpm	NULL
)	NULL
-2	NULL
to	NULL
10	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
.	NULL

Samples	NULL
were	NULL
loaded	NULL
onto	NULL
4	NULL
%	NULL
native	NULL
acrylamide	NULL
gel	NULL
(	NULL
Tris-glycine-EDTA	NULL
buffer	NULL
)	NULL
,	NULL
run	NULL
at	NULL
120	NULL
V	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
autoradiographed	NULL
for	NULL
1	NULL
to	NULL
6	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Preparation	NULL
of	NULL
AP1	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
for	NULL
2	NULL
to	NULL
3	NULL
h	NULL
with	NULL
PMA-A23187	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Fractions	NULL
containing	NULL
purified	NULL
API	NULL
were	NULL
obtained	NULL
as	NULL
described	NULL
by	NULL
Lee	NULL
et	NULL
al	NULL
.	NULL

(	NULL
16	NULL
)	NULL
,	NULL
with	NULL
slight	NULL
modifications	NULL
.	NULL

Proteins	NULL
were	NULL
precipitated	NULL
with	NULL
45	NULL
%	NULL
instead	NULL
of	NULL
53	NULL
%	NULL
(	NULL
NH	NULL
,	NULL
)	NULL
,	NULL
SO	NULL
,	NULL
,	NULL
and	NULL
a	NULL
Superose	NULL
6	NULL
(	NULL
Pharma-cia	NULL
)	NULL
instead	NULL
of	NULL
a	NULL
Sephacryl	NULL
S-300	NULL
gel	NULL
filtration	NULL
column	NULL
was	NULL
used	NULL
.	NULL

Fractions	NULL
eluted	NULL
with	NULL
0.5	NULL
M	NULL
NaCl	NULL
from	NULL
API	NULL
site	NULL
affinity	NULL
chromatography	NULL
were	NULL
shown	NULL
to	NULL
contain	NULL
API	NULL
activity	NULL
by	NULL
mobility	NULL
shift	NULL
assays	NULL
and	NULL
Western	NULL
blotting	NULL
(	NULL
immunoblot-ting	NULL
)	NULL
.	NULL

The	NULL
fractions	NULL
were	NULL
collected	NULL
into	NULL
one	NULL
pool	NULL
,	NULL
aliquoted	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
until	NULL
further	NULL
use	NULL
.	NULL

The	NULL
aliquots	NULL
had	NULL
a	NULL
protein	NULL
concentration	NULL
of	NULL
<	NULL
10	NULL
ng/pl	NULL
.	NULL

Similarly	NULL
obtained	NULL
API	NULL
from	NULL
HeLa	NULL
cells	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
M.	NULL
McMahon	NULL
(	NULL
DNAX	NULL
Research	NULL
Institute	NULL
)	NULL
.	NULL

RESULTS	NULL
Analysis	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
by	NULL
in	NULL
vitro	NULL
transcription	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
by	NULL
promoter	NULL
truncation	NULL
studies	NULL
that	NULL
a	NULL
fragment	NULL
containing	NULL
positions	NULL
-95	NULL
to	NULL
+27	NULL
of	NULL
the	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
region	NULL
can	NULL
confer	NULL
inducibility	NULL
to	NULL
reporter	NULL
plasmids	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
the	NULL
combination	NULL
of	NULL
the	NULL
phorbol	NULL
ester	NULL
PMA	NULL
and	NULL
the	NULL
calcium	NULL
ionophore	NULL
A23187	NULL
(	NULL
13	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
report	NULL
an	NULL
analysis	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
activity	NULL
in	NULL
vitro	NULL
by	NULL
runoff	NULL
transcription	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
TRANSCRIPTIONAL	NULL
REGULATION	NULL
OF	NULL
GM-CSF	NULL
IN	NULL
T	NULL
CELLS	NULL
7401	NULL
A	NULL
GM-	NULL
«	NULL
B/GC	NULL
CLEO	NULL
H—L-	NULL
(	NULL
-	NULL
LUC	NULL
pGM97Luc	NULL
pGM6OLuc	NULL
pGM32Luc	NULL
pGM19Luc	NULL
pGM+3Luc	NULL
pKC30	NULL
X	NULL
[	NULL
e	NULL
©	NULL
8	NULL
S	NULL
B	NULL
C	NULL
template	NULL
2	NULL
g	NULL
3	NULL
9	NULL
m	NULL
o	NULL
o	NULL
o	NULL
co	NULL
r_	NULL
(	NULL
2—1	NULL
fase	NULL
3	NULL
§	NULL
2	NULL
5.	NULL
s	NULL
<	NULL
fold	NULL
__	NULL
3.5	NULL
%	NULL
3.2	NULL
%	NULL
1.1	NULL
%	NULL
1.3	NULL
%	NULL
6	NULL
0	NULL
0	NULL
0	NULL
0	NULL
M	NULL
stimulation	NULL
-	NULL
+	NULL
-	NULL
_	NULL
%	NULL
age	NULL
;	NULL
.+	NULL
420nt	NULL
-	NULL
Q	NULL
cage	NULL
»	NULL
#	NULL
123456	NULL
1	NULL
.	NULL

AP	NULL
ent	NULL
:	NULL
i606	NULL
,	NULL
000735	NULL
1-6	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
by	NULL
in	NULL
vitro	NULL
transcription	NULL
assays	NULL
and	NULL
identification	NULL
of	NULL
CLEO	NULL
as	NULL
a	NULL
target	NULL
of	NULL
induction	NULL
signals	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
DNA	NULL
templates	NULL
.	NULL

The	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
sequences	NULL
containing	NULL
bp	NULL
-95	NULL
to	NULL
+27	NULL
fused	NULL
to	NULL
the	NULL
reporter	NULL
gene	NULL
encoding	NULL
luciferase	NULL
(	NULL
LUC	NULL
)	NULL
is	NULL
shown	NULL
at	NULL
the	NULL
top	NULL
.	NULL

Open	NULL
rectangles	NULL
indicate	NULL
functional	NULL
cis-acting	NULL
elements	NULL
.	NULL

The	NULL
arrow	NULL
shows	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
,	NULL
and	NULL
the	NULL
TATA	NULL
box	NULL
is	NULL
labeled	NULL
.	NULL

The	NULL
lines	NULL
below	NULL
indicate	NULL
the	NULL
extent	NULL
of	NULL
the	NULL
5	NULL
'	NULL
deletions	NULL
in	NULL
the	NULL
plasmids	NULL
.	NULL

Plasmid	NULL
pKC30	NULL
contains	NULL
a	NULL
mutated	NULL
CLEO	NULL
element	NULL
as	NULL
described	NULL
in	NULL
the	NULL
text	NULL
.	NULL

These	NULL
plasmids	NULL
were	NULL
digested	NULL
with	NULL
Fnu4HI	NULL
for	NULL
use	NULL
as	NULL
templates	NULL
for	NULL
transcription	NULL
assays	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Runoff	NULL
transcription	NULL
assays	NULL
on	NULL
truncated	NULL
templates	NULL
were	NULL
performed	NULL
with	NULL
53	NULL
pg	NULL
of	NULL
protein	NULL
per	NULL
assay	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
runoff	NULL
transcript	NULL
is	NULL
420	NULL
nucleotides	NULL
(	NULL
nt	NULL
)	NULL
long	NULL
.	NULL

The	NULL
size	NULL
marker	NULL
on	NULL
the	NULL
right	NULL
lane	NULL
(	NULL
M	NULL
)	NULL
is	NULL
Haelll-digested	NULL
$	NULL
X174	NULL
phage	NULL
DNA	NULL
that	NULL
had	NULL
been	NULL
radioactively	NULL
end	NULL
labeled	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Runoff	NULL
transcription	NULL
assays	NULL
using	NULL
nuclear	NULL
extracts	NULL
(	NULL
50	NULL
ug	NULL
per	NULL
assay	NULL
)	NULL
from	NULL
nonstimulated	NULL
(	NULL
-	NULL
)	NULL
and	NULL
stimulated	NULL
(	NULL
+	NULL
)	NULL
cells	NULL
.	NULL

Radioactivity	NULL
in	NULL
the	NULL
transcripts	NULL
was	NULL
quantitated	NULL
by	NULL
using	NULL
a	NULL
PhosphorImager	NULL
system	NULL
(	NULL
model	NULL
4008	NULL
;	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
and	NULL
normalized	NULL
to	NULL
values	NULL
obtained	NULL
for	NULL
AdML	NULL
promoter	NULL
templates	NULL
.	NULL

The	NULL
fold	NULL
stimulation	NULL
shows	NULL
the	NULL
ratio	NULL
between	NULL
the	NULL
transcription	NULL
activity	NULL
elicited	NULL
by	NULL
extracts	NULL
from	NULL
stimulated	NULL
versus	NULL
nonstimulated	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
three	NULL
experiments	NULL
using	NULL
different	NULL
preparations	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

assays	NULL
.	NULL

For	NULL
these	NULL
assays	NULL
,	NULL
we	NULL
used	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
Jurkat	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
treated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
A23187	NULL
.	NULL

As	NULL
templates	NULL
,	NULL
we	NULL
used	NULL
DNA	NULL
fragments	NULL
containing	NULL
the	NULL
promoter	NULL
that	NULL
had	NULL
been	NULL
truncated	NULL
at	NULL
different	NULL
distances	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
demonstrate	NULL
a	NULL
gradual	NULL
decrease	NULL
of	NULL
the	NULL
transcription	NULL
signal	NULL
as	NULL
the	NULL
size	NULL
of	NULL
the	NULL
deletion	NULL
increased	NULL
.	NULL

We	NULL
tentatively	NULL
concluded	NULL
that	NULL
both	NULL
elements	NULL
,	NULL
GM-	NULL
«	NULL
B/GC	NULL
and	NULL
CLEO	NULL
,	NULL
and	NULL
the	NULL
TATA	NULL
box	NULL
played	NULL
important	NULL
roles	NULL
in	NULL
the	NULL
extent	NULL
of	NULL
transcription	NULL
initiation	NULL
at	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
in	NULL
general	NULL
agreement	NULL
with	NULL
the	NULL
data	NULL
obtained	NULL
in	NULL
prior	NULL
transfection	NULL
studies	NULL
(	NULL
19	NULL
,	NULL
20	NULL
,	NULL
25	NULL
)	NULL
.	NULL

The	NULL
CLEO	NULL
element	NULL
confers	NULL
inducibility	NULL
to	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

We	NULL
next	NULL
investigated	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
cis-acting	NULL
elements	NULL
on	NULL
inducibility	NULL
by	NULL
comparing	NULL
in	NULL
vitro	NULL
transcription	NULL
activities	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
either	NULL
mock	NULL
stimulated	NULL
or	NULL
treated	NULL
with	NULL
PMA-A23187	NULL
.	NULL

We	NULL
found	NULL
that	NULL
transcription	NULL
of	NULL
both	NULL
the	NULL
GM97Luc	NULL
and	NULL
GM6O0Luc	NULL
templates	NULL
was	NULL
strongly	NULL
inducible	NULL
,	NULL
whereas	NULL
induction	NULL
was	NULL
not	NULL
observed	NULL
on	NULL
the	NULL
GM32Luc	NULL
template	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
slight	NULL
induction	NULL
seen	NULL
with	NULL
the	NULL
GM32Luc	NULL
template	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
observed	NULL
for	NULL
the	NULL
unrelated	NULL
AdML	NULL
promoter	NULL
template	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
;	NULL
see	NULL
also	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
GM-CSF	NULL
transcripts	NULL
were	NULL
quantified	NULL
and	NULL
normalized	NULL
to	NULL
the	NULL
AdML	NULL
signal	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

We	NULL
could	NULL
see	NULL
that	NULL
templates	NULL
truncated	NULL
up	NULL
to	NULL
position	NULL
-60	NULL
still	NULL
retained	NULL
inducibility	NULL
,	NULL
which	NULL
implied	NULL
that	NULL
at	NULL
least	NULL
one	NULL
of	NULL
the	NULL
determinants	NULL
for	NULL
inducibility	NULL
was	NULL
located	NULL
between	NULL
positions	NULL
-60	NULL
and	NULL
-32	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
CLEO	NULL
element	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
checked	NULL
the	NULL
requirement	NULL
for	NULL
CLEO	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
intact	NULL
GM-	NULL
«	NULL
B/GC	NULL
element	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
KC3O	NULL
template	NULL
,	NULL
which	NULL
is	NULL
analogous	NULL
to	NULL
GM97Luc	NULL
but	NULL
has	NULL
a	NULL
mutated	NULL
CLEO	NULL
element	NULL
.	NULL

The	NULL
mutation	NULL
,	NULL
which	NULL
abolished	NULL
induction	NULL
as	NULL
determined	NULL
by	NULL
transient	NULL
transfection	NULL
assays	NULL
,	NULL
is	NULL
a	NULL
substitution	NULL
of	NULL
the	NULL
residues	NULL
between	NULL
positions	NULL
-48	NULL
and	NULL
-43	NULL
for	NULL
a	NULL
Spel	NULL
site	NULL
(	NULL
5'-ACTAGT-3	NULL
'	NULL
)	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
demonstrate	NULL
that	NULL
the	NULL
CLEO	NULL
mutant	NULL
template	NULL
allowed	NULL
only	NULL
slight	NULL
induction	NULL
of	NULL
transcription	NULL
,	NULL
pinpointing	NULL
the	NULL
CLEO	NULL
element	NULL
as	NULL
an	NULL
essential	NULL
target	NULL
sequence	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
.	NULL

Induction	NULL
through	NULL
CLEO	NULL
requires	NULL
activation	NULL
of	NULL
signals	NULL
by	NULL
7402	NULL
MASUDA	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

IL2	NULL
AdML	NULL
template	NULL
GMeo	NULL
A	NULL
P	NULL
P/A	NULL
420nt	NULL
-	NULL
«	NULL
--	NULL
dllb	NULL
#	NULL
14	NULL
|	NULL
0.9	NULL
5	NULL
|	NULL
|	NULL
oe	NULL
|	NULL
09	NULL
Alli	NULL
-	NULL
lis	NULL
--	NULL
250nt	NULL
10	NULL
|12	NULL
|21i	NULL
|1.0	NULL
J|	NULL
1.0	NULL
|	NULL
1.7	NULL
|	NULL
1.5	NULL
|	NULL
fold	NULL
1.0	NULL
[	NULL
12	NULL
[	NULL
12	NULL
[	NULL
10.4	NULL
[	NULL
--	NULL
|	NULL
--	NULL
|	NULL
~-	NULL
|-	NULL
]	NULL
normalized	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

The	NULL
stimulation	NULL
in	NULL
vitro	NULL
of	NULL
GM-CSF	NULL
promoter	NULL
templates	NULL
requires	NULL
the	NULL
activation	NULL
of	NULL
two	NULL
signals	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
nuclear	NULL
extracts	NULL
(	NULL
50	NULL
ug	NULL
per	NULL
assay	NULL
)	NULL
from	NULL
cells	NULL
stimulated	NULL
under	NULL
different	NULL
conditions	NULL
:	NULL
nonstimulated	NULL
(	NULL
N	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
calcium	NULL
ionophore	NULL
A23187	NULL
at	NULL
1.0	NULL
M	NULL
(	NULL
A	NULL
)	NULL
,	NULL
PMA	NULL
at	NULL
50	NULL
ng/m	NULL
!	NULL

(	NULL
P	NULL
)	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
A23187	NULL
(	NULL
P/A	NULL
)	NULL
.	NULL

Runoff	NULL
transcripts	NULL
lengths	NULL
are	NULL
420	NULL
nucleotides	NULL
(	NULL
nt	NULL
)	NULL
for	NULL
GM95Luc	NULL
and	NULL
GM6OLuc	NULL
,	NULL
440	NULL
nucleotides	NULL
for	NULL
IL2Luc	NULL
,	NULL
and	NULL
250	NULL
nucleotides	NULL
for	NULL
AdML	NULL
templates	NULL
.	NULL

For	NULL
calculation	NULL
of	NULL
fold	NULL
induction	NULL
,	NULL
the	NULL
bands	NULL
were	NULL
quantitated	NULL
and	NULL
compared	NULL
with	NULL
the	NULL
signal	NULL
with	NULL
nonstimulated	NULL
extracts	NULL
;	NULL
the	NULL
results	NULL
are	NULL
shown	NULL
immediately	NULL
below	NULL
the	NULL
corresponding	NULL
lanes	NULL
.	NULL

These	NULL
values	NULL
,	NULL
normalized	NULL
to	NULL
the	NULL
values	NULL
obtained	NULL
for	NULL
the	NULL
AdML	NULL
template	NULL
,	NULL
are	NULL
presented	NULL
below	NULL
the	NULL
values	NULL
for	NULL
fold	NULL
induction	NULL
.	NULL

both	NULL
PMA	NULL
and	NULL
Ca**	NULL
ionophore	NULL
.	NULL

One	NULL
of	NULL
the	NULL
characteristics	NULL
of	NULL
induction	NULL
of	NULL
GM-CSF	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
is	NULL
shared	NULL
with	NULL
IL-2	NULL
gene	NULL
expression	NULL
,	NULL
is	NULL
the	NULL
requirement	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
pathways	NULL
by	NULL
treatment	NULL
with	NULL
both	NULL
PMA	NULL
and	NULL
Ca**	NULL
ionophore	NULL
(	NULL
4	NULL
)	NULL
.	NULL

We	NULL
examined	NULL
this	NULL
dual	NULL
requirement	NULL
by	NULL
measuring	NULL
transcription	NULL
of	NULL
the	NULL
GM-CSF	NULL
templates	NULL
in	NULL
vitro	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
mock	NULL
treated	NULL
,	NULL
treated	NULL
with	NULL
PMA	NULL
or	NULL
A23187	NULL
,	NULL
or	NULL
treated	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
the	NULL
two	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
the	NULL
transcription	NULL
activity	NULL
on	NULL
different	NULL
templates	NULL
was	NULL
assayed	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
double-stimulation	NULL
requirements	NULL
seen	NULL
with	NULL
the	NULL
IL2Luc	NULL
template	NULL
were	NULL
also	NULL
observed	NULL
for	NULL
both	NULL
the	NULL
GM97Luc	NULL
and	NULL
the	NULL
GM6OLuc	NULL
templates	NULL
,	NULL
while	NULL
the	NULL
activity	NULL
on	NULL
the	NULL
AdML	NULL
template	NULL
was	NULL
not	NULL
altered	NULL
significantly	NULL
.	NULL

Again	NULL
,	NULL
the	NULL
results	NULL
with	NULL
the	NULL
GM6OLuc	NULL
template	NULL
suggested	NULL
that	NULL
pathways	NULL
activated	NULL
by	NULL
both	NULL
PMA	NULL
and	NULL
Ca**	NULL
ionophore	NULL
exert	NULL
their	NULL
effects	NULL
through	NULL
the	NULL
CLEO	NULL
element	NULL
.	NULL

Multiple	NULL
CLEO-binding	NULL
factors	NULL
mediate	NULL
transcriptional	NULL
activation	NULL
.	NULL

To	NULL
clarify	NULL
the	NULL
role	NULL
of	NULL
the	NULL
CLEO	NULL
element	NULL
in	NULL
the	NULL
stimulation	NULL
of	NULL
transcription	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
transcription	NULL
assays	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
stimulated	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
depleted	NULL
of	NULL
CLEO-binding	NULL
proteins	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
depletion	NULL
of	NULL
>	NULL
80	NULL
%	NULL
of	NULL
the	NULL
CLEO-binding	NULL
proteins	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
reduced	NULL
transcription	NULL
through	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
but	NULL
had	NULL
minimal	NULL
effects	NULL
on	NULL
the	NULL
Ad	NULL
ML	NULL
promoter	NULL
template	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

We	NULL
believe	NULL
that	NULL
the	NULL
reduction	NULL
was	NULL
not	NULL
due	NULL
to	NULL
the	NULL
depletion	NULL
of	NULL
a	NULL
particular	NULL
basic	NULL
transcription	NULL
factor	NULL
because	NULL
addition	NULL
of	NULL
twice	NULL
the	NULL
amount	NULL
of	NULL
extract	NULL
doubled	NULL
the	NULL
AdML	NULL
signal	NULL
but	NULL
could	NULL
not	NULL
reconstitute	NULL
the	NULL
GM-CSF	NULL
transcription	NULL
to	NULL
its	NULL
original	NULL
signal	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

This	NULL
result	NULL
supports	NULL
the	NULL
view	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
CLEO-binding	NULL
factors	NULL
is	NULL
necessary	NULL
for	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
protein	NULL
factors	NULL
that	NULL
bound	NULL
the	NULL
CLEO	NULL
element	NULL
in	NULL
a	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

The	NULL
nuclear	NULL
extracts	NULL
used	NULL
were	NULL
from	NULL
stimulated	NULL
cells	NULL
;	NULL
a	NULL
labeled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
CLEO	NULL
element	NULL
was	NULL
used	NULL
as	NULL
the	NULL
target	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
and	NULL
others	NULL
reported	NULL
two	NULL
specific	NULL
band	NULL
shifts	NULL
that	NULL
reflected	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
CLEO	NULL
element	NULL
(	NULL
20	NULL
,	NULL
23	NULL
)	NULL
.	NULL

We	NULL
found	NULL
here	NULL
that	NULL
by	NULL
increasing	NULL
the	NULL
amount	NULL
of	NULL
extract	NULL
,	NULL
yet	NULL
another	NULL
specific	NULL
band	NULL
can	NULL
be	NULL
observed	NULL
.	NULL

We	NULL
refer	NULL
to	NULL
the	NULL
band	NULL
shifts	NULL
here	NULL
as	NULL
a	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

A	NULL
nonspecific	NULL
band	NULL
shift	NULL
and	NULL
could	NULL
be	NULL
observed	NULL
with	NULL
any	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

A	NULL
factor	NULL
related	NULL
or	NULL
identical	NULL
to	NULL
the	NULL
transcription	NULL
factor	NULL
API	NULL
binds	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
CLEO	NULL
element	NULL
.	NULL

During	NULL
our	NULL
characterization	NULL
of	NULL
CLEO-binding	NULL
factors	NULL
,	NULL
we	NULL
discovered	NULL
that	NULL
an	NULL
unlabeled	NULL
oligonucleotide	NULL
probe	NULL
containing	NULL
a	NULL
strong	NULL
API	NULL
site	NULL
(	NULL
22	NULL
)	NULL
could	NULL
efficiently	NULL
compete	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
B	NULL
to	NULL
the	NULL
CLEO	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
specific	NULL
,	NULL
as	NULL
the	NULL
oligonucleotide	NULL
gm-mul,2	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
GM-	NULL
«	NULL
B/GC	NULL
element	NULL
and	NULL
is	NULL
able	NULL
to	NULL
bind	NULL
the	NULL
factors	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Sp1	NULL
(	NULL
39	NULL
)	NULL
,	NULL
could	NULL
not	NULL
compete	NULL
for	NULL
B	NULL
binding	NULL
to	NULL
CLEO	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
B	NULL
template	NULL
x	NULL
g	NULL
Contro	NULL
420nt	NULL
-	NULL
«	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Multiple	NULL
CLEO-binding	NULL
factors	NULL
mediate	NULL
GM-CSF	NULL
transcriptional	NULL
activation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
In	NULL
vitro	NULL
transcription	NULL
of	NULL
GM-CSF	NULL
and	NULL
AdML	NULL
templates	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
stimulated	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
or	NULL
the	NULL
same	NULL
extracts	NULL
that	NULL
had	NULL
been	NULL
depleted	NULL
of	NULL
CLEO-binding	NULL
factors	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
extract	NULL
used	NULL
is	NULL
expressed	NULL
in	NULL
micrograms	NULL
of	NULL
protein	NULL
.	NULL

The	NULL
GM-CSF	NULL
template	NULL
used	NULL
contained	NULL
both	NULL
the	NULL
GM-	NULL
«	NULL
B/GC	NULL
and	NULL
CLEO	NULL
elements	NULL
and	NULL
was	NULL
prepared	NULL
by	NULL
Fnu4HI	NULL
digestion	NULL
of	NULL
plasmid	NULL
pGM6OLuc1,2	NULL
.	NULL

The	NULL
expected	NULL
length	NULL
of	NULL
the	NULL
transcript	NULL
is	NULL
420	NULL
nucleotides	NULL
(	NULL
nt	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Mobility	NULL
shift	NULL
assays	NULL
using	NULL
the	NULL
CLEO	NULL
probe	NULL
and	NULL
increasing	NULL
amounts	NULL
of	NULL
nuclear	NULL
extract	NULL
from	NULL
stimulated	NULL
cells	NULL
.	NULL

Bands	NULL
a	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
are	NULL
indicated	NULL
.	NULL

ns	NULL
,	NULL
nonspecific	NULL
band	NULL
;	NULL
free	NULL
,	NULL
unbound	NULL
probe	NULL
.	NULL

Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
probe	NULL
:	NULL
CLEO	NULL
AP1	NULL
igxB	NULL
I	NULL
1	NULL
[	NULL
1	NULL
competitor	NULL
antisera	NULL
AP1	NULL
protein	NULL
&	NULL
o	NULL
3	NULL
2	NULL
§	NULL
&	NULL
AP1	NULL
A2	NULL
``	NULL
bo	NULL
ms	NULL
Hels	NULL
#	NULL
=	NULL
.	NULL

S	NULL
$	NULL
8	NULL
=~	NULL
1	NULL
-	NULL
a	NULL
f	NULL
-	NULL
%	NULL
§	NULL
5	NULL
+	NULL
{	NULL
-M.	NULL
a	NULL
»	NULL
ns	NULL
-	NULL
tom	NULL
wad	NULL
1°	NULL
(	NULL
BMg	NULL
W109	NULL
)	NULL
15	NULL
19	NULL
20	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Relationship	NULL
of	NULL
CLEO-binding	NULL
factors	NULL
to	NULL
the	NULL
transcription	NULL
factor	NULL
AP1	NULL
.	NULL

Mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
oligonucleotide	NULL
probes	NULL
containing	NULL
the	NULL
CLEO	NULL
element	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
14	NULL
)	NULL
,	NULL
the	NULL
API	NULL
site	NULL
(	NULL
lanes	NULL
15	NULL
and	NULL
16	NULL
)	NULL
,	NULL
and	NULL
the	NULL
IgxB	NULL
site	NULL
(	NULL
lanes	NULL
17	NULL
to	NULL
20	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
4	NULL
pg	NULL
of	NULL
nuclear	NULL
extract	NULL
from	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
10	NULL
and	NULL
17	NULL
to	NULL
19	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
0.5	NULL
pl	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
or	NULL
1	NULL
wl	NULL
(	NULL
lanes	NULL
12	NULL
,	NULL
15	NULL
,	NULL
and	NULL
20	NULL
)	NULL
of	NULL
API	NULL
protein	NULL
from	NULL
Jurkat	NULL
cells	NULL
and	NULL
0.5	NULL
pl	NULL
(	NULL
lane	NULL
13	NULL
)	NULL
or	NULL
1	NULL
pl	NULL
(	NULL
lanes	NULL
14	NULL
and	NULL
16	NULL
)	NULL
of	NULL
API	NULL
protein	NULL
from	NULL
HeLa	NULL
cells	NULL
were	NULL
used	NULL
.	NULL

The	NULL
bindings	NULL
were	NULL
challenged	NULL
with	NULL
unlabeled	NULL
API	NULL
site	NULL
oligonucleotide	NULL
at	NULL
20-fold	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
50-fold	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
18	NULL
)	NULL
molar	NULL
excess	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
the	NULL
competition	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
oligonucleotide	NULL
GM1,2	NULL
at	NULL
20-fold	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
50-fold	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
molar	NULL
excess	NULL
.	NULL

Preincubation	NULL
of	NULL
reaction	NULL
mixtures	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
labeled	NULL
probe	NULL
with	NULL
nonimmune	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
«	NULL
Fos-alu	NULL
(	NULL
lanes	NULL
7	NULL
,	NULL
8	NULL
,	NULL
and	NULL
19	NULL
)	NULL
,	NULL
or	NULL
«	NULL
FosWB-2.3	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
antiserum	NULL
was	NULL
carried	NULL
out	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Antiserum	NULL
was	NULL
added	NULL
at	NULL
amounts	NULL
of	NULL
0.1	NULL
pl	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
9	NULL
)	NULL
or	NULL
0.2	NULL
pl	NULL
(	NULL
lanes	NULL
6	NULL
,	NULL
8	NULL
,	NULL
10	NULL
,	NULL
and	NULL
19	NULL
)	NULL
.	NULL

lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
oligonucleotide	NULL
bearing	NULL
the	NULL
AP1	NULL
site	NULL
did	NULL
not	NULL
compete	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
the	NULL
IgxB	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
17	NULL
and	NULL
18	NULL
)	NULL
.	NULL

The	NULL
y	NULL
band	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
these	NULL
CLEO-binding	NULL
assays	NULL
because	NULL
the	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
4	NULL
pg	NULL
of	NULL
nuclear	NULL
extract	NULL
,	NULL
a	NULL
concentration	NULL
that	NULL
makes	NULL
the	NULL
detection	NULL
of	NULL
the	NULL
y	NULL
band	NULL
difficult	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

On	NULL
closer	NULL
examination	NULL
,	NULL
we	NULL
found	NULL
sequence	NULL
similarity	NULL
between	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
CLEO	NULL
element	NULL
(	NULL
5'-TTAATCA-3	NULL
'	NULL
)	NULL
and	NULL
the	NULL
API	NULL
consensus	NULL
sequence	NULL
(	NULL
5'-TGASTCA-3	NULL
'	NULL
,	NULL
where	NULL
S	NULL
is	NULL
G	NULL
or	NULL
C	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
nucleotides	NULL
that	NULL
were	NULL
different	NULL
between	NULL
the	NULL
CLEO	NULL
element	NULL
sequence	NULL
and	NULL
the	NULL
API	NULL
site	NULL
consensus	NULL
sequence	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
noncritical	NULL
for	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
Fos-Jun	NULL
heterodimer	NULL
(	NULL
28	NULL
)	NULL
.	NULL

We	NULL
then	NULL
checked	NULL
the	NULL
effect	NULL
of	NULL
antisera	NULL
raised	NULL
against	NULL
c-Fos	NULL
protein	NULL
,	NULL
a	NULL
component	NULL
of	NULL
API	NULL
,	NULL
on	NULL
B	NULL
binding	NULL
to	NULL
CLEO	NULL
.	NULL

Two	NULL
different	NULL
c-Fos	NULL
antisera	NULL
,	NULL
«	NULL
Fos-alu	NULL
and	NULL
«	NULL
Fos-WB2.3	NULL
,	NULL
were	NULL
able	NULL
to	NULL
block	NULL
and/or	NULL
supershift	NULL
B	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
7	NULL
to	NULL
10	NULL
)	NULL
.	NULL

The	NULL
control	NULL
nonimmune	NULL
antiserum	NULL
did	NULL
not	NULL
affect	NULL
B	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
nor	NULL
did	NULL
the	NULL
anti-c-Fos	NULL
antiserum	NULL
affect	NULL
NF-KB	NULL
binding	NULL
to	NULL
the	NULL
IgkB	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
19	NULL
)	NULL
.	NULL

Similar	NULL
but	NULL
less	NULL
striking	NULL
findings	NULL
were	NULL
obtained	NULL
with	NULL
immunoglobulin	NULL
G	NULL
antibodies	NULL
specific	NULL
for	NULL
Jun	NULL
polypeptides	NULL
(	NULL
un-published	NULL
data	NULL
)	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
obtained	NULL
partially	NULL
purified	NULL
API	NULL
from	NULL
extracts	NULL
of	NULL
stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
checked	NULL
its	NULL
binding	NULL
activity	NULL
to	NULL
the	NULL
CLEO	NULL
probe	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
fractions	NULL
enriched	NULL
in	NULL
API	NULL
from	NULL
Jurkat	NULL
cells	NULL
gave	NULL
the	NULL
same	NULL
mobility	NULL
shifts	NULL
:	NULL
the	NULL
doublet	NULL
TRANSCRIPTIONAL	NULL
REGULATION	NULL
OF	NULL
GM-CSF	NULL
IN	NULL
T	NULL
CELLS	NULL
7403	NULL
of	NULL
bands	NULL
,	NULL
B	NULL
and	NULL
a	NULL
,	NULL
seen	NULL
with	NULL
crude	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
AP1	NULL
obtained	NULL
from	NULL
HeLa	NULL
cell	NULL
extracts	NULL
also	NULL
bound	NULL
to	NULL
the	NULL
CLEO	NULL
element	NULL
;	NULL
however	NULL
,	NULL
it	NULL
did	NULL
so	NULL
weakly	NULL
,	NULL
and	NULL
it	NULL
shifted	NULL
the	NULL
probe	NULL
to	NULL
only	NULL
one	NULL
defined	NULL
band	NULL
with	NULL
a	NULL
mobility	NULL
between	NULL
B	NULL
and	NULL
a	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
13	NULL
and	NULL
14	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
HeLa	NULL
API	NULL
did	NULL
bind	NULL
strongly	NULL
to	NULL
the	NULL
API	NULL
site	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
16	NULL
)	NULL
.	NULL

These	NULL
differences	NULL
between	NULL
the	NULL
Jurkat	NULL
and	NULL
HeLa	NULL
AP1	NULL
fractions	NULL
probably	NULL
reflect	NULL
heterogeneity	NULL
and/or	NULL
different	NULL
modifications	NULL
of	NULL
the	NULL
AP1	NULL
components	NULL
in	NULL
different	NULL
cellular	NULL
and	NULL
physiological	NULL
contexts	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
compared	NULL
various	NULL
features	NULL
of	NULL
AP1	NULL
binding	NULL
with	NULL
those	NULL
of	NULL
B	NULL
and	NULL
a	NULL
binding	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
results	NULL
presented	NULL
above	NULL
,	NULL
the	NULL
time	NULL
course	NULL
after	NULL
stimulation	NULL
and	NULL
the	NULL
response	NULL
to	NULL
CHX	NULL
and	NULL
CsA	NULL
were	NULL
similar	NULL
between	NULL
API	NULL
binding	NULL
and	NULL
B	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
binding	NULL
by	NULL
CHX	NULL
also	NULL
indicated	NULL
that	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
was	NULL
required	NULL
for	NULL
the	NULL
appearance	NULL
of	NULL
B-binding	NULL
activity	NULL
.	NULL

We	NULL
found	NULL
that	NULL
there	NULL
is	NULL
a	NULL
basal	NULL
«	NULL
activity	NULL
,	NULL
which	NULL
is	NULL
not	NULL
blocked	NULL
by	NULL
the	NULL
CHX	NULL
treatments	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

NFAT	NULL
binding	NULL
was	NULL
inhibited	NULL
by	NULL
CsA	NULL
and	NULL
was	NULL
included	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
of	NULL
CsA	NULL
action	NULL
.	NULL

Under	NULL
the	NULL
same	NULL
conditions	NULL
,	NULL
however	NULL
,	NULL
neither	NULL
API	NULL
binding	NULL
nor	NULL
B	NULL
and	NULL
a	NULL
bindings	NULL
were	NULL
affected	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
the	NULL
results	NULL
above	NULL
demonstrated	NULL
that	NULL
B	NULL
,	NULL
and	NULL
probably	NULL
a	NULL
,	NULL
were	NULL
related	NULL
to	NULL
the	NULL
transcription	NULL
factor	NULL
APL	NULL
.	NULL

CLEO	NULL
is	NULL
also	NULL
recognized	NULL
by	NULL
a	NULL
CsA-sensitive	NULL
factor	NULL
related	NULL
to	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
NFAT	NULL
.	NULL

Continuing	NULL
our	NULL
characterization	NULL
of	NULL
the	NULL
factors	NULL
binding	NULL
CLEO	NULL
,	NULL
we	NULL
checked	NULL
for	NULL
their	NULL
presence	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
stimulated	NULL
with	NULL
calcium	NULL
ionophore	NULL
A23187	NULL
,	NULL
PMA	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
the	NULL
two	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

A	NULL
basal	NULL
level	NULL
of	NULL
a	NULL
and	NULL
B	NULL
was	NULL
observed	NULL
in	NULL
unstimulated	NULL
extracts	NULL
;	NULL
this	NULL
level	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
A23187	NULL
to	NULL
the	NULL
cells	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
PMA	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
induced	NULL
the	NULL
amount	NULL
of	NULL
B	NULL
and	NULL
a	NULL
bands	NULL
.	NULL

Both	NULL
bands	NULL
were	NULL
further	NULL
increased	NULL
by	NULL
about	NULL
twofold	NULL
in	NULL
extracts	NULL
of	NULL
cells	NULL
stimulated	NULL
with	NULL
both	NULL
PMA	NULL
and	NULL
A23187	NULL
and	NULL
were	NULL
unaffected	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
y	NULL
band	NULL
was	NULL
observed	NULL
mainly	NULL
in	NULL
extracts	NULL
from	NULL
cells	NULL
stimulated	NULL
with	NULL
the	NULL
PMA-A23187	NULL
combination	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
found	NULL
that	NULL
CsA	NULL
could	NULL
block	NULL
the	NULL
appearance	NULL
of	NULL
y	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
in	NULL
a	NULL
manner	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
for	NULL
NFAT	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
alignment	NULL
of	NULL
the	NULL
CLEO	NULL
element	NULL
with	NULL
the	NULL
NFAT	NULL
binding	NULL
site	NULL
demonstrated	NULL
the	NULL
sequence	NULL
similarity	NULL
of	NULL
the	NULL
3	NULL
'	NULL
portion	NULL
of	NULL
CLEO	NULL
to	NULL
part	NULL
of	NULL
the	NULL
NFAT	NULL
site	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
a	NULL
mutation	NULL
at	NULL
position	NULL
-47	NULL
(	NULL
GM47	NULL
)	NULL
in	NULL
CLEO	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
,	NULL
which	NULL
completely	NULL
abolished	NULL
a	NULL
and	NULL
B	NULL
binding	NULL
,	NULL
allowed	NULL
binding	NULL
of	NULL
y	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
y	NULL
binding	NULL
and	NULL
«	NULL
/B	NULL
binding	NULL
can	NULL
occur	NULL
independently	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
y	NULL
binding	NULL
to	NULL
the	NULL
GM47	NULL
probe	NULL
was	NULL
also	NULL
dependent	NULL
on	NULL
stimulation	NULL
by	NULL
two	NULL
signals	NULL
and	NULL
was	NULL
blocked	NULL
by	NULL
treatment	NULL
with	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lanes	NULL
11	NULL
to	NULL
15	NULL
)	NULL
.	NULL

The	NULL
use	NULL
of	NULL
competition	NULL
experiments	NULL
provided	NULL
further	NULL
supporting	NULL
evidence	NULL
for	NULL
our	NULL
interpretation	NULL
of	NULL
the	NULL
y	NULL
band	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Unlabeled	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
NFAT	NULL
site	NULL
or	NULL
CLEO	NULL
mutated	NULL
at	NULL
position	NULL
-47	NULL
(	NULL
GM47	NULL
)	NULL
competed	NULL
efficiently	NULL
for	NULL
binding	NULL
of	NULL
y	NULL
but	NULL
not	NULL
of	NULL
B	NULL
and	NULL
a	NULL
to	NULL
the	NULL
CLEO	NULL
element	NULL
,	NULL
while	NULL
oligonucleotides	NULL
containing	NULL
mutations	NULL
at	NULL
both	NULL
positions	NULL
-43	NULL
and	NULL
-47	NULL
(	NULL
GM43,47	NULL
)	NULL
did	NULL
not	NULL
to	NULL
compete	NULL
for	NULL
y	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
9	NULL
)	NULL
.	NULL

Similar	NULL
competitions	NULL
were	NULL
seen	NULL
for	NULL
y	NULL
binding	NULL
to	NULL
the	NULL
GM47	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
10	NULL
to	NULL
18	NULL
)	NULL
.	NULL

Antisera	NULL
raised	NULL
against	NULL
c-Fos	NULL
protein	NULL
could	NULL
inhibit	NULL
y	NULL
binding	NULL
to	NULL
oligonucleotide	NULL
GM47	NULL
,	NULL
indicating	NULL
that	NULL
y	NULL
,	NULL
like	NULL
NFAT	NULL
,	NULL
has	NULL
a	NULL
component	NULL
related	NULL
to	NULL
the	NULL
API	NULL
factor	NULL
(	NULL
14	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
y	NULL
binding	NULL
being	NULL
due	NULL
to	NULL
a	NULL
factor	NULL
related	NULL
or	NULL
identical	NULL
to	NULL
NFAT	NULL
.	NULL

7404	NULL
MASUDA	NULL
ET	NULL
AL	NULL
.	NULL

probe	NULL
AP1	NULL
TT	NULL
17	NULL
@	NULL
wip	NULL
aan	NULL
wan	NULL
cab	NULL
win	NULL
wan	NULL
wit	NULL
wat	NULL
NFAT	NULL
we	NULL
uo	NULL
un	NULL
uo	NULL
us	NULL
us	NULL
us	NULL
us	NULL
us	NULL
2	NULL
44.915	NULL
31607	NULL
J	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

cycloheximide	NULL
(	NULL
ug/ml	NULL
)	NULL
cyclosporinA	NULL
(	NULL
ng/ml	NULL
ay	NULL
m	NULL
:	NULL
ven	NULL
t	NULL
s	NULL
o	NULL
<	NULL
.	NULL

r	NULL
bub	NULL
WW	NULL
wa	NULL
dug	NULL
tat	NULL
-	NULL
:	NULL
1000	NULL
=NFAT	NULL
10	NULL
11	NULL
.	NULL

12.93	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Similarities	NULL
between	NULL
factors	NULL
binding	NULL
the	NULL
CLEO	NULL
element	NULL
and	NULL
the	NULL
API	NULL
site	NULL
.	NULL

Mobility	NULL
shift	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
4	NULL
g	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
treated	NULL
under	NULL
different	NULL
conditions	NULL
.	NULL

The	NULL
bands	NULL
shifted	NULL
with	NULL
labeled	NULL
probes	NULL
bearing	NULL
the	NULL
CLEO	NULL
element	NULL
(	NULL
«	NULL
and	NULL
B	NULL
bands	NULL
)	NULL
,	NULL
the	NULL
API	NULL
site	NULL
,	NULL
and	NULL
the	NULL
NFAT	NULL
binding	NULL
site	NULL
are	NULL
indicated	NULL
.	NULL

ns	NULL
,	NULL
a	NULL
nonspecific	NULL
band	NULL
that	NULL
serves	NULL
as	NULL
an	NULL
internal	NULL
standard	NULL
for	NULL
protein	NULL
concentration	NULL
.	NULL

NFAT	NULL
binding	NULL
is	NULL
included	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
for	NULL
CsA	NULL
action	NULL
.	NULL

Lanes	NULL
1	NULL
to	NULL
9	NULL
represent	NULL
a	NULL
time	NULL
course	NULL
in	NULL
minutes	NULL
after	NULL
stimulation	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
and	NULL
A23187	NULL
(	NULL
1.0	NULL
M	NULL
)	NULL
.	NULL

The	NULL
stimulations	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
concentrations	NULL
of	NULL
CHX	NULL
(	NULL
lanes	NULL
10	NULL
to	NULL
13	NULL
)	NULL
or	NULL
CsA	NULL
(	NULL
lanes	NULL
14	NULL
to	NULL
18	NULL
)	NULL
were	NULL
done	NULL
for	NULL
a	NULL
period	NULL
of	NULL
3	NULL
h.	NULL
All	NULL
reagents	NULL
were	NULL
added	NULL
within	NULL
a	NULL
span	NULL
of	NULL
5	NULL
min	NULL
.	NULL

DISCUSSION	NULL
GM-CSF	NULL
gene	NULL
expression	NULL
is	NULL
induced	NULL
during	NULL
T-cell	NULL
activation	NULL
and	NULL
is	NULL
dependent	NULL
on	NULL
pathways	NULL
activated	NULL
by	NULL
both	NULL
phorbol	NULL
ester	NULL
and	NULL
calcium	NULL
ionophore	NULL
(	NULL
4	NULL
)	NULL
.	NULL

These	NULL
features	NULL
of	NULL
GM-CSF	NULL
expression	NULL
were	NULL
reflected	NULL
in	NULL
vitro	NULL
in	NULL
the	NULL
results	NULL
of	NULL
runoff	NULL
transcription	NULL
assays	NULL
.	NULL

We	NULL
found	NULL
that	NULL
templates	NULL
containing	NULL
a	NULL
small	NULL
region	NULL
(	NULL
positions	NULL
-60	NULL
to	NULL
+27	NULL
)	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
were	NULL
over	NULL
three	NULL
times	NULL
more	NULL
transcriptionally	NULL
active	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA-A23187	NULL
than	NULL
were	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
that	NULL
were	NULL
not	NULL
stimulated	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
two-signal	NULL
requirement	NULL
for	NULL
induction	NULL
,	NULL
as	NULL
both	NULL
phorbol	NULL
ester	NULL
and	NULL
calcium	NULL
ionophore	NULL
treatments	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
necessary	NULL
for	NULL
optimal	NULL
stimulation	NULL
of	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
transcription	NULL
activity	NULL
of	NULL
truncated	NULL
promoters	NULL
revealed	NULL
that	NULL
one	NULL
of	NULL
the	NULL
targets	NULL
for	NULL
this	NULL
regulation	NULL
was	NULL
the	NULL
CLEO	NULL
element	NULL
located	NULL
between	NULL
positions	NULL
-54	NULL
and	NULL
-40	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
we	NULL
found	NULL
that	NULL
mutations	NULL
in	NULL
the	NULL
CLEO	NULL
sequence	NULL
reduced	NULL
transcription	NULL
stimulation	NULL
to	NULL
almost	NULL
basal	NULL
levels	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
intact	NULL
upstream	NULL
GM-	NULL
«	NULL
kB/GC	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
strong	NULL
correlation	NULL
between	NULL
induction	NULL
of	NULL
transcription	NULL
and	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
protein	NULL
factors	NULL
that	NULL
bound	NULL
to	NULL
the	NULL
CLEO	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

We	NULL
believe	NULL
that	NULL
this	NULL
correlation	NULL
is	NULL
significant	NULL
because	NULL
depletion	NULL
of	NULL
these	NULL
factors	NULL
from	NULL
the	NULL
nuclear	NULL
extracts	NULL
caused	NULL
reduction	NULL
of	NULL
transcription	NULL
activity	NULL
on	NULL
GM-CSF	NULL
templates	NULL
while	NULL
eliciting	NULL
minimal	NULL
changes	NULL
of	NULL
the	NULL
activity	NULL
on	NULL
the	NULL
control	NULL
AdML	NULL
templates	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Our	NULL
in	NULL
vitro	NULL
results	NULL
showed	NULL
that	NULL
the	NULL
CLEO	NULL
element	NULL
alone	NULL
was	NULL
able	NULL
to	NULL
confer	NULL
inducibility	NULL
and	NULL
that	NULL
the	NULL
GM-	NULL
«	NULL
B/GC	NULL
site	NULL
enhanced	NULL
the	NULL
induction	NULL
elicited	NULL
through	NULL
the	NULL
CLEO	NULL
element	NULL
.	NULL

In	NULL
our	NULL
previous	NULL
transfection	NULL
assays	NULL
,	NULL
however	NULL
,	NULL
the	NULL
CLEO	NULL
element	NULL
alone	NULL
appeared	NULL
to	NULL
be	NULL
insufficient	NULL
to	NULL
confer	NULL
induction	NULL
to	NULL
the	NULL
reporter	NULL
gene	NULL
(	NULL
13	NULL
,	NULL
19	NULL
)	NULL
.	NULL

This	NULL
lack	NULL
of	NULL
induction	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
could	NULL
be	NULL
overcome	NULL
by	NULL
multimerization	NULL
of	NULL
the	NULL
CLEO	NULL
element	NULL
;	NULL
we	NULL
observed	NULL
good	NULL
inducibility	NULL
when	NULL
three	NULL
copies	NULL
of	NULL
CLEO	NULL
were	NULL
placed	NULL
in	NULL
front	NULL
of	NULL
the	NULL
GM-CSF	NULL
basal	NULL
promoter	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
Nimer	NULL
et	NULL
al	NULL
.	NULL

have	NULL
shown	NULL
that	NULL
reporter	NULL
plasmids	NULL
containing	NULL
truncations	NULL
up	NULL
to	NULL
the	NULL
CLEO	NULL
element	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
without	NULL
the	NULL
element	NULL
)	NULL
of	NULL
the	NULL
corresponding	NULL
human	NULL
sequences	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
still	NULL
retain	NULL
inducibility	NULL
in	NULL
response	NULL
to	NULL
PMA-phytohemagglutinin	NULL
treatments	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
view	NULL
that	NULL
CLEO	NULL
serves	NULL
as	NULL
a	NULL
target	NULL
for	NULL
induction	NULL
signals	NULL
is	NULL
also	NULL
supported	NULL
by	NULL
in	NULL
vivo	NULL
experimental	NULL
results	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
factors	NULL
binding	NULL
CLEO	NULL
since	NULL
they	NULL
were	NULL
good	NULL
candidates	NULL
for	NULL
effecting	NULL
the	NULL
stimulation	NULL
.	NULL

As	NULL
it	NULL
turned	NULL
out	NULL
,	NULL
CLEO	NULL
is	NULL
a	NULL
complex	NULL
element	NULL
that	NULL
is	NULL
bound	NULL
by	NULL
multiple	NULL
factors	NULL
of	NULL
different	NULL
sequence	NULL
specificity	NULL
.	NULL

One	NULL
factor	NULL
seems	NULL
to	NULL
be	NULL
the	NULL
well-known	NULL
transcription	NULL
factor	NULL
AP1	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
indicated	NULL
that	NULL
we	NULL
can	NULL
relate	NULL
the	NULL
B	NULL
and	NULL
a	NULL
bands	NULL
,	NULL
which	NULL
bind	NULL
CLEO	NULL
,	NULL
to	NULL
the	NULL
transcription	NULL
factor	NULL
API	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

First	NULL
,	NULL
both	NULL
bands	NULL
were	NULL
abolished	NULL
by	NULL
an	NULL
oligonucleotide	NULL
bearing	NULL
a	NULL
strong	NULL
API	NULL
site	NULL
.	NULL

Second	NULL
,	NULL
an	NULL
anti-c-Fos	NULL
antiserum	NULL
blocked	NULL
or	NULL
supershifted	NULL
the	NULL
bands	NULL
corresponding	NULL
to	NULL
B	NULL
and	NULL
«	NULL
.	NULL

Third	NULL
,	NULL
partially	NULL
purified	NULL
API	NULL
from	NULL
Jurkat	NULL
cells	NULL
was	NULL
able	NULL
to	NULL
bind	NULL
and	NULL
shift	NULL
the	NULL
CLEO	NULL
probe	NULL
to	NULL
the	NULL
B-	NULL
and	NULL
«	NULL
-band	NULL
posi-tions	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
appearance	NULL
of	NULL
AP1-binding	NULL
activity	NULL
upon	NULL
stimulation	NULL
closely	NULL
paralleled	NULL
that	NULL
of	NULL
the	NULL
B	NULL
band	NULL
.	NULL

They	NULL
were	NULL
induced	NULL
with	NULL
the	NULL
same	NULL
kinetics	NULL
and	NULL
showed	NULL
similar	NULL
sensitivity	NULL
to	NULL
the	NULL
drug	NULL
CHX	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
this	NULL
vein	NULL
,	NULL
it	NULL
is	NULL
noted	NULL
that	NULL
CHX	NULL
inhibits	NULL
the	NULL
expression	NULL
of	NULL
GM-CSF	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
27	NULL
,	NULL
29	NULL
)	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
induction	NULL
of	NULL
API	NULL
(	NULL
B	NULL
activity	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CHX	NULL
may	NULL
provide	NULL
one	NULL
explanation	NULL
for	NULL
the	NULL
inhibition	NULL
.	NULL

Further	NULL
work	NULL
is	NULL
needed	NULL
to	NULL
clarify	NULL
the	NULL
difference	NULL
between	NULL
the	NULL
constitutively	NULL
present	NULL
«	NULL
band	NULL
and	NULL
the	NULL
B	NULL
band	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
API	NULL
binding	NULL
,	NULL
however	NULL
,	NULL
could	NULL
not	NULL
explain	NULL
the	NULL
stimulation	NULL
at	NULL
CLEO	NULL
entirely	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
PMA-only-stimulated	NULL
cells	NULL
contained	NULL
reasonably	NULL
good	NULL
API1-binding	NULL
activity	NULL
but	NULL
supported	NULL
little	NULL
transcription	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
6A	NULL
)	NULL
.	NULL

This	NULL
was	NULL
not	NULL
unexpected	NULL
,	NULL
as	NULL
sequences	NULL
located	NULL
3	NULL
'	NULL
to	NULL
the	NULL
API	NULL
site	NULL
within	NULL
the	NULL
CLEO	NULL
element	NULL
had	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
CLEO	NULL
action	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Conceivably	NULL
,	NULL
an	NULL
additional	NULL
factor	NULL
that	NULL
was	NULL
subject	NULL
to	NULL
regulation	NULL
by	NULL
the	NULL
calcium	NULL
signal	NULL
was	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
.	NULL

Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
A	NULL
probe	NULL
:	NULL
CLEO	NULL
NFAT	NULL
GM47	NULL
PMA	NULL
=-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
-	NULL
-+	NULL
++	NULL
A23187	NULL
-	NULL
+	NULL
-	NULL
+	NULL
+	NULL
=	NULL
+	NULL
=	NULL
+	NULL
+	NULL
=o	NULL
$	NULL
o	NULL
=o	NULL
++	NULL
CSA	NULL
=-	NULL
<	NULL
<	NULL
-	NULL
$	NULL
<	NULL
--	NULL
-	NULL
$	NULL
-	NULL
--	NULL
-+	NULL
®	NULL
cask	NULL
tag	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9101112131415	NULL
CLEO	NULL
CLEO	NULL
GM47	NULL
43.47	NULL
NFAT	NULL
~	NULL
el	NULL
aol	NULL
aol	NULL
ml	NULL
GM47	NULL
CLEQ	NULL
GM47	NULL
43.47	NULL
NFAT	NULL
5	NULL
eee	NULL
meee	NULL
d	NULL
e-	NULL
]	NULL
c	NULL
Y-	NULL
©	NULL
f	NULL
|	NULL
l	NULL
wit	NULL
C	NULL
:	NULL
-0.	NULL
no	NULL
-	NULL
CKB	NULL
an	NULL
an	NULL
-	NULL
»	NULL
#	NULL
«	NULL
-	NULL
us	NULL
as	NULL
Cif	NULL
us	NULL
as	NULL
us	NULL
--	NULL
ub	NULL
--	NULL
ap	NULL
a*	NULL
aFos	NULL
4	NULL
free	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
1011121314151617181920	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

CLEO	NULL
is	NULL
bound	NULL
by	NULL
a	NULL
factor	NULL
related	NULL
to	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Mobility	NULL
shift	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
9	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
stimulated	NULL
for	NULL
3	NULL
h	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
and	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
treatment	NULL
of	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
,	NULL
A23187	NULL
(	NULL
1.0	NULL
wM	NULL
)	NULL
,	NULL
and	NULL
CsA	NULL
(	NULL
1.0	NULL
ug/ml	NULL
)	NULL
.	NULL

Labeled	NULL
probes	NULL
contained	NULL
the	NULL
CLEO	NULL
element	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
,	NULL
the	NULL
NFAT	NULL
binding	NULL
site	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
,	NULL
and	NULL
the	NULL
CLEO	NULL
element	NULL
with	NULL
a	NULL
mutation	NULL
corresponding	NULL
to	NULL
position	NULL
-47	NULL
(	NULL
GM47	NULL
)	NULL
(	NULL
lanes	NULL
11	NULL
to	NULL
15	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Mobility	NULL
shift	NULL
assays	NULL
using	NULL
the	NULL
CLEO	NULL
and	NULL
GM47	NULL
labeled	NULL
probes	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
stimulated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
PMA	NULL
and	NULL
A23187	NULL
at	NULL
the	NULL
concentrations	NULL
specified	NULL
above	NULL
.	NULL

Unlabeled	NULL
oligonucleotides	NULL
bearing	NULL
the	NULL
CLEO	NULL
element	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
11	NULL
,	NULL
and	NULL
12	NULL
)	NULL
,	NULL
CLEO	NULL
mutated	NULL
at	NULL
position	NULL
-47	NULL
(	NULL
GM47	NULL
)	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
5	NULL
,	NULL
13	NULL
,	NULL
and	NULL
14	NULL
)	NULL
,	NULL
CLEO	NULL
mutated	NULL
at	NULL
positions	NULL
-43	NULL
and	NULL
-47	NULL
(	NULL
GM43,47	NULL
)	NULL
(	NULL
lanes	NULL
6	NULL
,	NULL
7	NULL
,	NULL
15	NULL
,	NULL
and	NULL
16	NULL
)	NULL
,	NULL
and	NULL
the	NULL
NFAT	NULL
binding	NULL
site	NULL
(	NULL
lanes	NULL
8	NULL
,	NULL
9	NULL
,	NULL
17	NULL
,	NULL
and	NULL
18	NULL
)	NULL
were	NULL
added	NULL
as	NULL
competitors	NULL
.	NULL

For	NULL
sequence	NULL
information	NULL
,	NULL
see	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

The	NULL
competitors	NULL
were	NULL
added	NULL
at	NULL
a	NULL
20-fold	NULL
(	NULL
even-numbered	NULL
lanes	NULL
)	NULL
or	NULL
50-fold	NULL
(	NULL
odd-numbered	NULL
lanes	NULL
)	NULL
molar	NULL
excess	NULL
.	NULL

Preincubation	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
labeled	NULL
GM47	NULL
probe	NULL
with	NULL
0.2	NULL
pl	NULL
of	NULL
nonimmune	NULL
(	NULL
lane	NULL
19	NULL
)	NULL
or	NULL
0.2	NULL
pl	NULL
of	NULL
«	NULL
Fos-alu	NULL
(	NULL
lane	NULL
20	NULL
)	NULL
antiserum	NULL
was	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

ns	NULL
,	NULL
nonspecific	NULL
band	NULL
.	NULL

TRANSCRIPTIONAL	NULL
REGULATION	NULL
OF	NULL
GM-CSF	NULL
IN	NULL
T	NULL
CELLS	NULL
7405	NULL
Indeed	NULL
,	NULL
we	NULL
observed	NULL
the	NULL
binding	NULL
to	NULL
the	NULL
CLEO	NULL
probe	NULL
of	NULL
another	NULL
factor	NULL
,	NULL
as	NULL
reflected	NULL
by	NULL
the	NULL
y	NULL
band	NULL
.	NULL

Interestingly	NULL
,	NULL
this	NULL
factor	NULL
had	NULL
characteristics	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
NFAT	NULL
(	NULL
33	NULL
)	NULL
.	NULL

NFAT	NULL
and	NULL
y	NULL
shifted	NULL
their	NULL
respective	NULL
probes	NULL
to	NULL
similar	NULL
positions	NULL
,	NULL
and	NULL
both	NULL
were	NULL
inhibited	NULL
or	NULL
supershifted	NULL
by	NULL
anti-Fos	NULL
antibodies	NULL
(	NULL
14	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
similarity	NULL
was	NULL
further	NULL
supported	NULL
by	NULL
sequence	NULL
homology	NULL
between	NULL
the	NULL
3	NULL
'	NULL
half	NULL
of	NULL
CLEO	NULL
and	NULL
part	NULL
of	NULL
the	NULL
NFAT	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
similar	NULL
to	NULL
NFAT	NULL
binding	NULL
,	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
y	NULL
band	NULL
in	NULL
the	NULL
nucleus	NULL
required	NULL
cell	NULL
stimulation	NULL
with	NULL
both	NULL
PMA	NULL
and	NULL
A23187	NULL
.	NULL

The	NULL
double-stimulation	NULL
requirement	NULL
for	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
y	NULL
band	NULL
is	NULL
significant	NULL
since	NULL
it	NULL
correlates	NULL
with	NULL
the	NULL
double-stimulation	NULL
requirement	NULL
for	NULL
GM-CSF	NULL
induction	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
induction	NULL
of	NULL
the	NULL
y	NULL
band	NULL
by	NULL
the	NULL
immunosup-pressant	NULL
CsA	NULL
also	NULL
correlated	NULL
with	NULL
the	NULL
inhibition	NULL
by	NULL
CsA	NULL
of	NULL
GM-CSF	NULL
expression	NULL
(	NULL
4	NULL
)	NULL
and	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
activity	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
(	NULL
38	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
we	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
overexpression	NULL
of	NULL
cal-cineurin	NULL
,	NULL
a	NULL
calmodulin-dependent	NULL
protein	NULL
phosphatase	NULL
,	NULL
up-regulates	NULL
GM-CSF	NULL
promoter	NULL
activity	NULL
(	NULL
38	NULL
)	NULL
in	NULL
a	NULL
manner	NULL
similar	NULL
to	NULL
IL-2	NULL
promoter	NULL
activation	NULL
(	NULL
6	NULL
,	NULL
26	NULL
)	NULL
.	NULL

In	NULL
the	NULL
IL-2	NULL
system	NULL
,	NULL
calcineurin	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
augment	NULL
NFAT-dependent	NULL
transcription	NULL
.	NULL

Consequently	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
NFAT-like	NULL
factor	NULL
bound	NULL
to	NULL
CLEO	NULL
(	NULL
and	NULL
responsible	NULL
for	NULL
the	NULL
y	NULL
band	NULL
)	NULL
confers	NULL
on	NULL
GM-CSF	NULL
gene	NULL
expression	NULL
effects	NULL
similar	NULL
to	NULL
those	NULL
exerted	NULL
by	NULL
NFAT	NULL
on	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

These	NULL
findings	NULL
also	NULL
suggest	NULL
that	NULL
GM-CSF	NULL
and	NULL
IL-2	NULL
promoters	NULL
may	NULL
share	NULL
components	NULL
in	NULL
their	NULL
transcriptional	NULL
regu-lation	NULL
,	NULL
thus	NULL
providing	NULL
an	NULL
explanation	NULL
for	NULL
the	NULL
similar	NULL
induction	NULL
kinetics	NULL
and	NULL
signal	NULL
requirements	NULL
between	NULL
their	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
analogy	NULL
may	NULL
be	NULL
extended	NULL
since	NULL
similar	NULL
CLEO	NULL
elements	NULL
are	NULL
found	NULL
upstream	NULL
the	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IL-5	NULL
genes	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

It	NULL
is	NULL
thus	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
CLEO	NULL
sites	NULL
in	NULL
the	NULL
promoters/enhancers	NULL
of	NULL
these	NULL
T-cell-derived	NULL
cytokine	NULL
genes	NULL
indicates	NULL
a	NULL
role	NULL
for	NULL
factors	NULL
related	NULL
to	NULL
AP1	NULL
and	NULL
NFAT	NULL
in	NULL
their	NULL
coordinate	NULL
induction	NULL
during	NULL
T-cell	NULL
activation	NULL
.	NULL

This	NULL
idea	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
recent	NULL
identification	NULL
by	NULL
Cockerill	NULL
et	NULL
al	NULL
.	NULL

(	NULL
7	NULL
)	NULL
of	NULL
a	NULL
716-bp	NULL
inducible	NULL
CsA-sensitive	NULL
enhancer	NULL
located	NULL
3	NULL
kb	NULL
upstream	NULL
the	NULL
GM-CSF	NULL
gene	NULL
.	NULL

This	NULL
enhancer	NULL
contains	NULL
four	NULL
API	NULL
sites	NULL
,	NULL
three	NULL
of	NULL
which	NULL
are	NULL
similar	NULL
to	NULL
CLEO	NULL
and	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
NFAT	NULL
.	NULL

This	NULL
also	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
induction	NULL
of	NULL
GM-CSF	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
distant	NULL
enhancer	NULL
in	NULL
conjunction	NULL
with	NULL
a	NULL
promoter-proximal	NULL
element	NULL
.	NULL

It	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
determine	NULL
the	NULL
cooperation	NULL
,	NULL
if	NULL
any	NULL
,	NULL
between	NULL
this	NULL
enhancer	NULL
and	NULL
the	NULL
promoter-proximal	NULL
CLEO	NULL
during	NULL
the	NULL
activation	NULL
of	NULL
GM-CSF	NULL
gene	NULL
transcription	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
in	NULL
additional	NULL
experiments	NULL
that	NULL
NFAT-like	NULL
(	NULL
y	NULL
)	NULL
binding	NULL
to	NULL
CLEO	NULL
spans	NULL
a	NULL
sequence	NULL
of	NULL
at	NULL
least	NULL
12	NULL
bp	NULL
that	NULL
includes	NULL
the	NULL
AP1	NULL
binding	NULL
site	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
their	NULL
binding	NULL
sites	NULL
overlap	NULL
.	NULL

However	NULL
,	NULL
we	NULL
can	NULL
not	NULL
at	NULL
this	NULL
point	NULL
determine	NULL
the	NULL
relative	NULL
importance	NULL
of	NULL
a	NULL
particular	NULL
factor	NULL
in	NULL
induction	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
,	NULL
results	NULL
from	NULL
transient	NULL
transfection	NULL
assays	NULL
seem	NULL
to	NULL
indicate	NULL
that	NULL
all	NULL
factors	NULL
are	NULL
necessary	NULL
,	NULL
as	NULL
all	NULL
mutations	NULL
tested	NULL
that	NULL
block	NULL
the	NULL
binding	NULL
of	NULL
one	NULL
or	NULL
two	NULL
factors	NULL
also	NULL
showed	NULL
limited	NULL
induction	NULL
(	NULL
20	NULL
,	NULL
24	NULL
)	NULL
.	NULL

We	NULL
do	NULL
know	NULL
that	NULL
both	NULL
AP1	NULL
and	NULL
NFAT	NULL
have	NULL
the	NULL
ability	NULL
to	NULL
bind	NULL
the	NULL
CLEO	NULL
element	NULL
independently	NULL
.	NULL

The	NULL
mutation	NULL
at	NULL
position	NULL
-47	NULL
within	NULL
the	NULL
CLEO	NULL
element	NULL
,	NULL
for	NULL
instance	NULL
,	NULL
blocks	NULL
API	NULL
binding	NULL
but	NULL
retains	NULL
the	NULL
NFAT-like	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

This	NULL
is	NULL
not	NULL
an	NULL
artifact	NULL
,	NULL
as	NULL
we	NULL
have	NULL
now	NULL
found	NULL
that	NULL
NFAT	NULL
purified	NULL
over	NULL
NFAT	NULL
site	NULL
affinity	NULL
columns	NULL
can	NULL
bind	NULL
the	NULL
CLEO	NULL
probe	NULL
as	NULL
a	NULL
single	NULL
band	NULL
shifting	NULL
the	NULL
probe	NULL
to	NULL
a	NULL
position	NULL
that	NULL
corresponds	NULL
to	NULL
y	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Further	NULL
characterization	NULL
of	NULL
the	NULL
components	NULL
of	NULL
all	NULL
CLEO-binding	NULL
factors	NULL
,	NULL
the	NULL
interplay	NULL
of	NULL
their	NULL
binding	NULL
to	NULL
7406	NULL
MASUDA	NULL
ET	NULL
AL	NULL
.	NULL

GM-xB	NULL
80	NULL
-80	NULL
10	NULL
60	NULL
AP1	NULL
site	NULL
»	NULL
TGAGTCA	NULL
ATTAATCATTTCCTG	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bror..	NULL
40	NULL
«	NULL
30	NULL
20	NULL
10	NULL
AACTGTGTATATAAGAGCTCTTTTG-CAGTGAGCCCAGTACGT	NULL
TGAAACAGTTTTTCCTCC	NULL
_	NULL
hIL2	NULL
(	NULL
NFAT	NULL
)	NULL
TIGAAACAAATTTTCCTCC	NULL
_	NULL
mIL2	NULL
(	NULL
NFAT	NULL
)	NULL
TIGAGTICAGGCTTCCCCT	NULL
-	NULL
hIL3	NULL
(	NULL
CLEO	NULL
)	NULL
AAACTITGATTTTCCCTC	NULL
_	NULL
hiL4	NULL
(	NULL
CLEO	NULL
)	NULL
AAACTIGCATTTTCCCTT	NULL
_	NULL
mil4	NULL
(	NULL
CLEO	NULL
)	NULL
AITATIGATTTCCTCT	NULL
-	NULL
m	NULL
,	NULL
hIL5	NULL
(	NULL
CLEO	NULL
)	NULL
ATITAATCATTTCCTCT	NULL
_	NULL
hGMCSF	NULL
(	NULL
CLEO	NULL
)	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Graphic	NULL
representation	NULL
of	NULL
the	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
and	NULL
similarities	NULL
of	NULL
the	NULL
CLEO	NULL
element	NULL
to	NULL
the	NULL
binding	NULL
sites	NULL
of	NULL
API	NULL
and	NULL
NFAT	NULL
.	NULL

The	NULL
sequence	NULL
spans	NULL
positions	NULL
-95	NULL
to	NULL
+3	NULL
of	NULL
the	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
cis-acting	NULL
sequences	NULL
are	NULL
enclosed	NULL
by	NULL
ellipses	NULL
,	NULL
the	NULL
TATA	NULL
box	NULL
is	NULL
doubled	NULL
underlined	NULL
,	NULL
and	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
is	NULL
shown	NULL
by	NULL
a	NULL
thick	NULL
arrow	NULL
.	NULL

The	NULL
substitution	NULL
mutations	NULL
at	NULL
positions	NULL
-43	NULL
and	NULL
-47	NULL
are	NULL
shown	NULL
by	NULL
thin	NULL
arrows	NULL
.	NULL

Outlined	NULL
letters	NULL
represent	NULL
nucleotides	NULL
that	NULL
are	NULL
different	NULL
or	NULL
absent	NULL
in	NULL
the	NULL
human	NULL
GM-CSF	NULL
(	NULL
hGMCSF	NULL
)	NULL
promoter	NULL
.	NULL

Homology	NULL
between	NULL
the	NULL
5	NULL
'	NULL
half	NULL
of	NULL
the	NULL
API	NULL
site	NULL
and	NULL
the	NULL
3	NULL
'	NULL
half	NULL
of	NULL
the	NULL
CLEO	NULL
element	NULL
to	NULL
the	NULL
human	NULL
IL-2	NULL
(	NULL
bIL2	NULL
)	NULL
NFAT	NULL
binding	NULL
site	NULL
is	NULL
indicated	NULL
with	NULL
vertical	NULL
lines	NULL
.	NULL

Below	NULL
the	NULL
human	NULL
IL-2	NULL
NFAT	NULL
site	NULL
,	NULL
the	NULL
sequences	NULL
of	NULL
other	NULL
similar	NULL
elements	NULL
located	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
other	NULL
T-cell-derived	NULL
cytokine	NULL
genes	NULL
are	NULL
presented	NULL
.	NULL

The	NULL
respective	NULL
AP1-like	NULL
site	NULL
for	NULL
each	NULL
element	NULL
is	NULL
underlined	NULL
.	NULL

Both	NULL
human	NULL
and	NULL
murine	NULL
IL-2	NULL
(	NULL
mIL2	NULL
)	NULL
NFAT	NULL
sites	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
confer	NULL
inducibility	NULL
(	NULL
14	NULL
,	NULL
33	NULL
)	NULL
.	NULL

The	NULL
human	NULL
IL-3	NULL
CLEO	NULL
site	NULL
contains	NULL
the	NULL
API	NULL
site	NULL
reported	NULL
to	NULL
be	NULL
required	NULL
for	NULL
IL-3	NULL
promoter	NULL
induction	NULL
(	NULL
17	NULL
,	NULL
34	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
positions	NULL
of	NULL
CLEO	NULL
elements	NULL
in	NULL
IL-4	NULL
and	NULL
IL-5	NULL
are	NULL
shown	NULL
in	NULL
reference	NULL
20	NULL
.	NULL

CLEO	NULL
,	NULL
and	NULL
their	NULL
relationship	NULL
to	NULL
the	NULL
basic	NULL
transcription	NULL
machinery	NULL
should	NULL
help	NULL
clarify	NULL
the	NULL
mechanism	NULL
of	NULL
induction	NULL
of	NULL
GM-CSF	NULL
expression	NULL
through	NULL
the	NULL
CLEO	NULL
element	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
T.	NULL
Curran	NULL
and	NULL
T.	NULL
Kerppola	NULL
for	NULL
providing	NULL
antisera	NULL
against	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
,	NULL
D.	NULL
Robison	NULL
for	NULL
oligonucleotide	NULL
synthesis	NULL
,	NULL
and	NULL
M.	NULL
McMahon	NULL
for	NULL
HeLa	NULL
AP1	NULL
.	NULL

We	NULL
thank	NULL
P.	NULL
Berg	NULL
,	NULL
Y.	NULL
Kaziro	NULL
,	NULL
and	NULL
C.	NULL
Yanofsky	NULL
for	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
and	NULL
S.	NULL
Miyatake	NULL
,	NULL
Y.	NULL
Naito	NULL
,	NULL
M.	NULL
Nakafuku	NULL
,	NULL
I.	NULL
Matsuda	NULL
,	NULL
A.	NULL
Voronova	NULL
,	NULL
and	NULL
K.	NULL
Conger	NULL
for	NULL
helpful	NULL
discussions	NULL
and	NULL
collaboration	NULL
.	NULL

DNAX	NULL
Research	NULL
Institute	NULL
of	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
is	NULL
supported	NULL
by	NULL
Schering-Plough	NULL
Co.	NULL
REFERENCES	NULL
1	NULL
.	NULL

Abate	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
T.	NULL
Curran	NULL
.	NULL

1990	NULL
.	NULL

Encounters	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
on	NULL
the	NULL
road	NULL
to	NULL
AP-1	NULL
.	NULL

Semin	NULL
.	NULL

Cancer	NULL
Biol	NULL
.	NULL

1:19-26	NULL
.	NULL

2	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
role	NULL
of	NULL
Jun	NULL
,	NULL
Fos	NULL
and	NULL
the	NULL
AP-1	NULL
complex	NULL
in	NULL
cell-proliferation	NULL
and	NULL
transformation	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1072:129-157	NULL
.	NULL

3	NULL
.	NULL

Arai	NULL
,	NULL
K.	NULL
I.	NULL
,	NULL
F.	NULL
Lee	NULL
,	NULL
A.	NULL
Miyajima	NULL
,	NULL
S.	NULL
Miyatake	NULL
,	NULL
N.	NULL
Arai	NULL
,	NULL
and	NULL
T.	NULL
Yokota	NULL
.	NULL

1990	NULL
.	NULL

Cytokines	NULL
:	NULL
coordinators	NULL
of	NULL
immune	NULL
and	NULL
inflammatory	NULL
responses	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

59:783-836	NULL
.	NULL

4	NULL
.	NULL

Arai	NULL
,	NULL
N.	NULL
,	NULL
Y.	NULL
Naito	NULL
,	NULL
M.	NULL
Watanabe	NULL
,	NULL
E.	NULL
S.	NULL
Masuda	NULL
,	NULL
Y.	NULL
Yamaguchi-Iwai	NULL
,	NULL
A.	NULL
Tsuboi	NULL
,	NULL
T.	NULL
Heike	NULL
,	NULL
I.	NULL
Matsuda	NULL
,	NULL
K.	NULL
Yokota	NULL
,	NULL
N.	NULL
Koyano-Nakagawa	NULL
,	NULL
H.	NULL
J.	NULL
Lee	NULL
,	NULL
M.	NULL
Muramatsu	NULL
,	NULL
T.	NULL
Yokota	NULL
,	NULL
and	NULL
K.	NULL
Arai	NULL
.	NULL

1992	NULL
.	NULL

Activation	NULL
of	NULL
lymphokines	NULL
genes	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
role	NULL
of	NULL
cis-acting	NULL
DNA	NULL
elements	NULL
that	NULL
respond	NULL
to	NULL
T	NULL
cell	NULL
activation	NULL
signals	NULL
.	NULL

Pharmac	NULL
.	NULL

Ther	NULL
.	NULL

55:303-318	NULL
.	NULL

5	NULL
.	NULL

Brorson	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
B.	NULL
Beverly	NULL
,	NULL
S.	NULL
M.	NULL
Kang	NULL
,	NULL
M.	NULL
Lenardo	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Schwartz	NULL
.	NULL

1991	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
cytokine	NULL
genes	NULL
in	NULL
nontransformed	NULL
T	NULL
cells	NULL
.	NULL

Apparent	NULL
constitutive	NULL
signals	NULL
in	NULL
run-on	NULL
assays	NULL
can	NULL
be	NULL
caused	NULL
by	NULL
repeat	NULL
sequences	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147	NULL
:	NULL
3601-3609	NULL
.	NULL

6	NULL
.	NULL

Clipstone	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
calcineurin	NULL
as	NULL
a	NULL
key	NULL
signalling	NULL
enzyme	NULL
in	NULL
T-lymphocyte	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
357:695-697	NULL
.	NULL

7	NULL
.	NULL

Cockerill	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
M.	NULL
F.	NULL
Shannon	NULL
,	NULL
A.	NULL
G.	NULL
Bert	NULL
,	NULL
G.	NULL
R.	NULL
Ryan	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Vadas	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor/interleukin	NULL
3	NULL
locus	NULL
is	NULL
regulated	NULL
by	NULL
an	NULL
inducible	NULL
cyclosporin	NULL
A-sensitive	NULL
enhancer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2466-2470	NULL
.	NULL

8	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

Conaway	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Conaway	NULL
.	NULL

1988	NULL
.	NULL

ATP	NULL
activates	NULL
transcription	NULL
initiation	NULL
from	NULL
promoters	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
reversible	NULL
step	NULL
prior	NULL
to	NULL
RNA	NULL
synthesis	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263:2962-2968.	NULL
.	NULL

Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
1989	NULL
.	NULL

Contingent	NULL
genetic	NULL
regulatory	NULL
events	NULL
in	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Science	NULL
243:355-361	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebowitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

Emmel	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
C.	NULL
L.	NULL
Verweij	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
K.	NULL
M.	NULL
Higgins	NULL
,	NULL
E.	NULL
Lacy	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1989	NULL
.	NULL

Cyclosporin	NULL
A	NULL
specifically	NULL
inhibits	NULL
function	NULL
of	NULL
nuclear	NULL
proteins	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Science	NULL
246:1617-1620	NULL
.	NULL

Gabrielsen	NULL
,	NULL
O.	NULL
S.	NULL
,	NULL
E.	NULL
Hornes	NULL
,	NULL
L.	NULL
Korsnes	NULL
,	NULL
A.	NULL
Ruet	NULL
,	NULL
and	NULL
T.	NULL
B.	NULL
Oyen	NULL
.	NULL

1989	NULL
.	NULL

Magnetic	NULL
DNA	NULL
affinity	NULL
purification	NULL
of	NULL
yeast	NULL
transcription	NULL
factor	NULL
tau-a	NULL
new	NULL
purification	NULL
principle	NULL
for	NULL
the	NULL
ultrara-pid	NULL
isolation	NULL
of	NULL
near	NULL
homogeneous	NULL
factor	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6253-6267	NULL
.	NULL

Heike	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Miyatake	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1989	NULL
.	NULL

Bovine	NULL
papilloma	NULL
virus	NULL
encoded	NULL
E2	NULL
protein	NULL
activates	NULL
lymphokine	NULL
genes	NULL
through	NULL
DNA	NULL
elements	NULL
,	NULL
distinct	NULL
from	NULL
the	NULL
consensus	NULL
motif	NULL
,	NULL
in	NULL
the	NULL
long	NULL
control	NULL
region	NULL
of	NULL
its	NULL
own	NULL
genome	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:1411-1417	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
A.	NULL
V.	NULL
Valge	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
356:801-864	NULL
.	NULL

Klausner	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
and	NULL
L.	NULL
E.	NULL
Samelson	NULL
.	NULL

1991	NULL
.	NULL

T	NULL
cell	NULL
antigen	NULL
receptor	NULL
activation	NULL
pathways	NULL
:	NULL
the	NULL
tyrosine	NULL
kinase	NULL
connection	NULL
.	NULL

Cell	NULL
64:875-878	NULL
.	NULL

Lee	NULL
,	NULL
W.	NULL
,	NULL
P.	NULL
Mitchell	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1987	NULL
.	NULL

Purified	NULL
transcription	NULL
factor	NULL
AP-1	NULL
interacts	NULL
with	NULL
TPA-inducible	NULL
enhancer	NULL
elements	NULL
.	NULL

Cell	NULL
49:741-752	NULL
.	NULL

Mathey	NULL
,	NULL
P.	NULL
B.	NULL
,	NULL
N.	NULL
C.	NULL
Andrews	NULL
,	NULL
H.	NULL
S.	NULL
Murphy	NULL
,	NULL
S.	NULL
G.	NULL
Kreissman	NULL
,	NULL
and	NULL
D.	NULL
G.	NULL
Nathan	NULL
.	NULL

1990	NULL
.	NULL

Positive	NULL
and	NULL
negative	NULL
elements	NULL
regulate	NULL
human	NULL
interleukin	NULL
3	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:5046-5050	NULL
.	NULL

Miyatake	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Otsuka	NULL
,	NULL
T.	NULL
Yokota	NULL
,	NULL
F.	NULL
Lee	NULL
,	NULL
and	NULL
K.	NULL
Arai	NULL
.	NULL

1985	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
chromosomal	NULL
gene	NULL
for	NULL
granulocyte-macrophage	NULL
colony	NULL
stimulating	NULL
factor	NULL
:	NULL
comparison	NULL
of	NULL
the	NULL
mouse	NULL
and	NULL
human	NULL
genes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

4:2561-2568	NULL
.	NULL

Miyatake	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
K.	NULL
Arai	NULL
.	NULL

1988	NULL
.	NULL

T-cell	NULL
activation	NULL
signals	NULL
and	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
l-en-coded	NULL
p40x	NULL
protein	NULL
activate	NULL
the	NULL
mouse	NULL
granulocyte-macrophage	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29.	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
through	NULL
a	NULL
common	NULL
DNA	NULL
element	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:5581-5587	NULL
.	NULL

Miyatake	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
Shlomai	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1991	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
mouse	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
gene	NULL
promoter	NULL
:	NULL
nuclear	NULL
factors	NULL
that	NULL
interact	NULL
with	NULL
an	NULL
element	NULL
shared	NULL
by	NULL
three	NULL
lymphokine	NULL
genes-those	NULL
for	NULL
GM-CSF	NULL
,	NULL
interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
,	NULL
and	NULL
IL-5	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:5894-5901	NULL
.	NULL

Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
H.	NULL
Walker	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

NF-kappa	NULL
B	NULL
:	NULL
a	NULL
family	NULL
of	NULL
inducible	NULL
and	NULL
differentially	NULL
expressed	NULL
enhancer-binding	NULL
proteins	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:10028-10032	NULL
.	NULL

Nakabeppu	NULL
,	NULL
Y.	NULL
,	NULL
K.	NULL
Ryder	NULL
,	NULL
and	NULL
D.	NULL
Nathans	NULL
.	NULL

1988	NULL
.	NULL

DNA	NULL
binding	NULL
activities	NULL
of	NULL
three	NULL
murine	NULL
Jun	NULL
proteins	NULL
:	NULL
stimulation	NULL
by	NULL
Fos	NULL
.	NULL

Cell	NULL
55:907-915	NULL
.	NULL

Nimer	NULL
,	NULL
S.	NULL
1991	NULL
.	NULL

Tax	NULL
responsiveness	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
is	NULL
mediated	NULL
by	NULL
mitogen-inducible	NULL
sequences	NULL
other	NULL
than	NULL
kappa	NULL
B	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

3:997-1004	NULL
.	NULL

Nimer	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
Fraser	NULL
,	NULL
J.	NULL
Richards	NULL
,	NULL
M.	NULL
Lynch	NULL
,	NULL
and	NULL
J.	NULL
Gasson	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
repeated	NULL
sequence	NULL
CATT	NULL
(	NULL
A/T	NULL
)	NULL
is	NULL
required	NULL
for	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
activity	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:6084-6088	NULL
.	NULL

Nimer	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
E.	NULL
A.	NULL
Morita	NULL
,	NULL
M.	NULL
J.	NULL
Martis	NULL
,	NULL
W.	NULL
Wachsman	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Gasson	NULL
.	NULL

1988	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
human	NULL
granulocyte	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
region	NULL
by	NULL
genetic	NULL
analysis	NULL
:	NULL
correlation	NULL
with	NULL
DNase	NULL
I	NULL
footprinting	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:1979-1984	NULL
.	NULL

O'Keefe	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
J.	NULL
Tamura	NULL
,	NULL
R.	NULL
L.	NULL
Kincaid	NULL
,	NULL
M.	NULL
J.	NULL
Tocci	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
O'Neill	NULL
.	NULL

1992	NULL
.	NULL

FK-506-	NULL
and	NULL
CsA-sensitive	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
by	NULL
calcineurin	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
357	NULL
:	NULL
692-694	NULL
.	NULL

Razanajaona	NULL
,	NULL
D.	NULL
,	NULL
C.	NULL
Maroc	NULL
,	NULL
M.	NULL
Lopez	NULL
,	NULL
P.	NULL
Mannoni	NULL
,	NULL
and	NULL
J.	NULL
Gabert	NULL
.	NULL

1992	NULL
.	NULL

Shift	NULL
from	NULL
posttranscriptional	NULL
to	NULL
predominant	NULL
transcriptional	NULL
control	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
during	NULL
activation	NULL
of	NULL
human	NULL
Jurkat	NULL
cells	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

3:299-305	NULL
.	NULL

Risse	NULL
,	NULL
G.	NULL
,	NULL
K.	NULL
Jooss	NULL
,	NULL
M.	NULL
Neuberg	NULL
,	NULL
H.	NULL
J.	NULL
Bruller	NULL
,	NULL
and	NULL
R.	NULL
Muller	NULL
.	NULL

1989	NULL
.	NULL

Asymmetrical	NULL
recognition	NULL
of	NULL
the	NULL
palindromic	NULL
API	NULL
binding	NULL
site	NULL
(	NULL
TRE	NULL
)	NULL
by	NULL
Fos	NULL
protein	NULL
complexes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:3825-3832	NULL
.	NULL

Ryan	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
S.	NULL
E.	NULL
Milton	NULL
,	NULL
A.	NULL
F.	NULL
Lopez	NULL
,	NULL
P.	NULL
G.	NULL
Bardy	NULL
,	NULL
M.	NULL
A.	NULL
TRANSCRIPTIONAL	NULL
REGULATION	NULL
OF	NULL
GM-CSF	NULL
IN	NULL
T	NULL
CELLS	NULL
30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38.	NULL
.	NULL

Tsuboi	NULL
,	NULL
A.	NULL
,	NULL
K.	NULL
Sugimoto	NULL
,	NULL
J.	NULL
Yodoi	NULL
,	NULL
S.	NULL
Miyatake	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
7407	NULL
Vadas	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Shannon	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
interleukin-3	NULL
mRNA	NULL
accumulation	NULL
is	NULL
controlled	NULL
at	NULL
both	NULL
the	NULL
transcriptional	NULL
and	NULL
posttranscriptional	NULL
level	NULL
.	NULL

Blood	NULL
77:1195-1202	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerie	NULL
.	NULL

1990	NULL
.	NULL

NF-kB	NULL
as	NULL
inducible	NULL
transcriptional	NULL
activator	NULL
of	NULL
the	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:1281-1286	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
M.	NULL
Muller	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1989	NULL
.	NULL

Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
'mini-extracts	NULL
'	NULL
,	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6420	NULL
.	NULL

Shannon	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
J.	NULL
R.	NULL
Gamble	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Vadas	NULL
.	NULL

1988	NULL
.	NULL

Nuclear	NULL
proteins	NULL
interacting	NULL
with	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
human	NULL
granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:674-678	NULL
.	NULL

Shaw	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
P.	NULL
J.	NULL
Utz	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
J.	NULL
J.	NULL
Toole	NULL
,	NULL
E.	NULL
A.	NULL
Emmel	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
putative	NULL
regulator	NULL
of	NULL
early	NULL
T	NULL
cell	NULL
activation	NULL
genes	NULL
.	NULL

Science	NULL
241:202-205	NULL
.	NULL

Shoemaker	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
R.	NULL
Hromas	NULL
,	NULL
and	NULL
K.	NULL
Kaushansky	NULL
,	NULL
.	NULL

1990	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
interleukin	NULL
3	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:9650-9654	NULL
.	NULL

Sigal	NULL
,	NULL
N.	NULL
H.	NULL
,	NULL
and	NULL
F.	NULL
J.	NULL
Dumont	NULL
.	NULL

1992	NULL
.	NULL

Cyclosporin	NULL
A	NULL
,	NULL
FK-506	NULL
,	NULL
and	NULL
rapamycin	NULL
:	NULL
pharmacologic	NULL
probes	NULL
of	NULL
lymphocyte	NULL
signal	NULL
transduction	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

10:519-560	NULL
.	NULL

Sugimoto	NULL
,	NULL
K.	NULL
,	NULL
A.	NULL
Tsuboi	NULL
,	NULL
S.	NULL
Miyatake	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1990	NULL
.	NULL

Inducible	NULL
and	NULL
non-inducible	NULL
factors	NULL
co-operatively	NULL
activate	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
by	NULL
interacting	NULL
with	NULL
two	NULL
adjacent	NULL
DNA	NULL
motifs	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

2:787-794	NULL
.	NULL

Tokumitsu	NULL
,	NULL
H.	NULL
,	NULL
E.	NULL
S.	NULL
Masuda	NULL
,	NULL
A.	NULL
Tsuboi	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

Tsuboi	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

Arai	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
nuclear	NULL
factor	NULL
NF-GM2	NULL
that	NULL
interacts	NULL
with	NULL
a	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
essential	NULL
for	NULL
its	NULL
induction	NULL
in	NULL
responses	NULL
to	NULL
T-cell	NULL
activation	NULL
:	NULL
purification	NULL
from	NULL
human	NULL
T-cell	NULL
leukemia	NULL
line	NULL
Jurkat	NULL
cells	NULL
and	NULL
similarity	NULL
to	NULL
NF-kappa	NULL
B.	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

3:807-817.	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
Imboden	NULL
,	NULL
K.	NULL
Hardy	NULL
,	NULL
B.	NULL
Manger	NULL
,	NULL
C.	NULL
Terhorst	NULL
,	NULL
and	NULL
J.	NULL
Stobo	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
T3/antigen	NULL
receptor	NULL
complex	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

4:593-619	NULL
.	NULL

